Physical	O
and	O
functional	O
interaction	O
between	O
the	O
human	B-protein
T-cell	I-protein
lymphotropic	I-protein
virus	I-protein
type	I-protein
1	I-protein
Tax1	I-protein
protein	I-protein
and	O
the	O
CCAAT	B-protein
binding	I-protein
protein	I-protein
NF-Y	B-protein
.	O

Tax1	B-protein
,	O
a	O
potent	O
activator	O
of	O
human	O
T-cell	O
lymphotropic	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
transcription	O
,	O
has	O
been	O
shown	O
to	O
modulate	O
expression	O
of	O
many	O
cellular	B-DNA
genes	I-DNA
.	O

Tax1	B-protein
does	O
not	O
bind	O
DNA	O
directly	O
but	O
regulates	O
transcription	O
through	O
protein-protein	O
interactions	O
with	O
sequence-specific	B-protein
transcription	I-protein
factors	I-protein
.	O

Using	O
the	O
yeast	O
two-hybrid	O
system	O
to	O
screen	O
for	O
proteins	O
which	O
interact	O
with	O
Tax1	B-protein
,	O
we	O
isolated	O
the	O
B	B-protein
subunit	I-protein
of	O
the	O
CCAAT	B-protein
binding	I-protein
protein	I-protein
NF-Y	B-protein
from	O
a	O
HeLa	B-DNA
cDNA	I-DNA
library	I-DNA
.	O

The	O
interaction	O
of	O
Tax1	B-protein
with	O
NF-YB	B-protein
was	O
specific	O
in	O
that	O
NF-YB	B-protein
did	O
not	O
interact	O
with	O
a	O
variety	O
of	O
other	O
transcription	B-protein
factors	I-protein
,	O
including	O
human	B-protein
immunodeficiency	I-protein
virus	I-protein
Tat	I-protein
,	O
human	B-protein
papillomavirus	I-protein
E6	I-protein
,	O
and	O
Bicoid	B-protein
,	O
or	O
with	O
the	O
M7	B-protein
(	I-protein
amino	I-protein
acids	I-protein
29CP-AS	I-protein
)	I-protein
Tax1	I-protein
mutant	I-protein
.	O

However	O
,	O
NF-YB	B-protein
did	O
interact	O
with	O
the	O
C-terminal	B-protein
Tax1	I-protein
mutants	I-protein
M22	B-protein
(	O
130TL-AS	B-protein
)	O
and	O
M47	B-protein
(	O
319LL-RS	B-protein
)	O
.	O

We	O
also	O
show	O
that	O
in	O
vitro-translated	O
NF-YB	B-protein
specifically	O
bound	O
to	O
a	O
glutathione	B-protein
S-transferase-Tax1	I-protein
fusion	I-protein
protein	I-protein
.	O

Further	O
,	O
Tax1	B-protein
coimmunoprecipitated	O
with	O
NF-Y	B-protein
from	O
nuclear	O
extracts	O
of	O
HTLV-1-transformed	B-cell_type
cells	I-cell_type
,	O
providing	O
evidence	O
for	O
in	O
vivo	O
interaction	O
of	O
Tax1	B-protein
and	O
NF-YB	B-protein
.	O

We	O
further	O
demonstrate	O
that	O
Tax1	B-protein
specifically	O
activated	O
the	O
NF-Y-responsive	B-DNA
DQbeta	I-DNA
promoter	I-DNA
,	O
as	O
well	O
as	O
a	O
minimal	B-DNA
promoter	I-DNA
which	O
contains	O
only	O
the	O
Y-box	B-DNA
element	I-DNA
.	O

In	O
addition	O
,	O
mutation	O
of	O
the	O
Y-box	B-DNA
element	I-DNA
alone	O
abrogated	O
Tax1	B-protein
-mediated	O
activation	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
Tax1	B-protein
interacts	O
with	O
NF-Y	B-protein
through	O
the	O
B	B-protein
subunit	I-protein
and	O
that	O
this	O
interaction	O
results	O
in	O
activation	O
of	O
the	O
major	B-DNA
histocompatibility	I-DNA
complex	I-DNA
class	I-DNA
II	I-DNA
promoter	I-DNA
.	O

Through	O
activation	O
of	O
this	O
and	O
other	O
NF-Y	B-protein
driven	O
promoters	B-DNA
,	O
the	O
Tax1	B-protein
-NF-Y	B-protein
interaction	O
may	O
play	O
a	O
critical	O
role	O
in	O
causing	O
cellular	O
transformation	O
and	O
HTLV-1	O
pathogenesis	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Mar	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
1236-1243	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Physical	NULL
and	NULL
Functional	NULL
Interaction	NULL
between	NULL
the	NULL
Human	NULL
T-Cell	NULL
Lymphotropic	NULL
Virus	NULL
Type	NULL
1	NULL
Tax	NULL
;	NULL
,	NULL
Protein	NULL
and	NULL
the	NULL
CCAAT	NULL
Binding	NULL
Protein	NULL
NF-Y	NULL
CYNTHIA	NULL
A.	NULL
PISE-MASISON	NULL
,	NULL
JURGEN	NULL
KAREN	NULL
E.	NULL
anp	NULL
JOHN	NULL
N.	NULL
BRADY*	NULL
Virus	NULL
Tumor	NULL
Biology	NULL
Section	NULL
,	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892-5055	NULL
Received	NULL
10	NULL
September	NULL
1996/Returned	NULL
for	NULL
modification	NULL
5	NULL
November	NULL
1996/Accepted	NULL
3	NULL
December	NULL
1996	NULL
Tax	NULL
,	NULL
,	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
transcription	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
modulate	NULL
expression	NULL
of	NULL
many	NULL
cellular	NULL
genes	NULL
.	NULL

Tax	NULL
,	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
but	NULL
regulates	NULL
transcription	NULL
through	NULL
protein-protein	NULL
interactions	NULL
with	NULL
sequence-specific	NULL
transcription	NULL
factors	NULL
.	NULL

Using	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
to	NULL
screen	NULL
for	NULL
proteins	NULL
which	NULL
interact	NULL
with	NULL
Tax	NULL
;	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
B	NULL
subunit	NULL
of	NULL
the	NULL
CCAAT	NULL
binding	NULL
protein	NULL
NF-Y	NULL
from	NULL
a	NULL
HeLa	NULL
cDNA	NULL
library	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
Tax	NULL
,	NULL
with	NULL
NF-YB	NULL
was	NULL
specific	NULL
in	NULL
that	NULL
NF-YB	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
Tat	NULL
,	NULL
human	NULL
papillomavirus	NULL
E6	NULL
,	NULL
and	NULL
Bicoid	NULL
,	NULL
or	NULL
with	NULL
the	NULL
M7	NULL
(	NULL
amino	NULL
acids	NULL
~°CP-AS	NULL
)	NULL
Tax	NULL
,	NULL
mutant	NULL
.	NULL

However	NULL
,	NULL
NF-YB	NULL
did	NULL
interact	NULL
with	NULL
the	NULL
C-terminal	NULL
Tax	NULL
,	NULL
mutants	NULL
M22	NULL
(	NULL
°TL-AS	NULL
)	NULL
and	NULL
M47	NULL
@	NULL
*	NULL
LL-RS	NULL
)	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
in	NULL
vitro-translated	NULL
NF-YB	NULL
specifically	NULL
bound	NULL
to	NULL
a	NULL
glutathione	NULL
S-transferase-Tax	NULL
,	NULL
fusion	NULL
protein	NULL
.	NULL

Further	NULL
,	NULL
Tax	NULL
,	NULL
coimmunoprecipitated	NULL
with	NULL
NF-Y	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
HTLV-1-transformed	NULL
cells	NULL
,	NULL
providing	NULL
evidence	NULL
for	NULL
in	NULL
vivo	NULL
interaction	NULL
of	NULL
Tax	NULL
,	NULL
and	NULL
NF-YB	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
Tax	NULL
,	NULL
specifically	NULL
activated	NULL
the	NULL
NF-Y-responsive	NULL
DQB	NULL
promoter	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
minimal	NULL
promoter	NULL
which	NULL
contains	NULL
only	NULL
the	NULL
Y-box	NULL
element	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Y-box	NULL
element	NULL
alone	NULL
abrogated	NULL
Tax	NULL
,	NULL
-mediated	NULL
activation	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
Tax	NULL
;	NULL
interacts	NULL
with	NULL
NF-Y	NULL
through	NULL
the	NULL
B	NULL
subunit	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
promoter	NULL
.	NULL

Through	NULL
activation	NULL
of	NULL
this	NULL
and	NULL
other	NULL
NF-Y	NULL
driven	NULL
promoters	NULL
,	NULL
the	NULL
Tax	NULL
,	NULL
-NF-Y	NULL
interaction	NULL
may	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
causing	NULL
cellular	NULL
transformation	NULL
and	NULL
HTLV-1	NULL
pathogenesis	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotrophic	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
is	NULL
the	NULL
causative	NULL
agent	NULL
of	NULL
the	NULL
aggressive	NULL
,	NULL
usually	NULL
fatal	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
see	NULL
references	NULL
22	NULL
,	NULL
23	NULL
,	NULL
48	NULL
and	NULL
86	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
linked	NULL
HTLV-1	NULL
with	NULL
additional	NULL
and	NULL
clinically	NULL
diverse	NULL
human	NULL
diseases	NULL
(	NULL
31	NULL
,	NULL
46	NULL
,	NULL
53	NULL
,	NULL
59	NULL
,	NULL
63	NULL
,	NULL
65	NULL
)	NULL
.	NULL

The	NULL
best	NULL
characterized	NULL
of	NULL
these	NULL
is	NULL
a	NULL
progressive	NULL
demyelinating	NULL
syndrome	NULL
termed	NULL
HTLV-1-associated	NULL
myelopathy	NULL
(	NULL
HAM	NULL
)	NULL
or	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
TSP	NULL
)	NULL
(	NULL
see	NULL
references	NULL
22	NULL
,	NULL
23	NULL
,	NULL
48	NULL
,	NULL
and	NULL
86	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
long	NULL
incubation	NULL
period	NULL
between	NULL
viral	NULL
exposure	NULL
and	NULL
disease	NULL
onset	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
HTLV-1	NULL
pathogenesis	NULL
is	NULL
still	NULL
unclear	NULL
.	NULL

It	NULL
is	NULL
clear	NULL
that	NULL
host	NULL
cell	NULL
control	NULL
of	NULL
HTLV-1	NULL
replication	NULL
is	NULL
a	NULL
primary	NULL
determinant	NULL
of	NULL
virus	NULL
expression	NULL
and	NULL
subsequent	NULL
disease	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
variation	NULL
of	NULL
viral	NULL
sequences	NULL
among	NULL
different	NULL
infected	NULL
groups	NULL
have	NULL
not	NULL
revealed	NULL
any	NULL
particular	NULL
determinant	NULL
which	NULL
distinguishes	NULL
onset	NULL
of	NULL
a	NULL
particular	NULL
HTLV-1	NULL
associated	NULL
disease	NULL
(	NULL
18	NULL
,	NULL
44	NULL
,	NULL
60	NULL
,	NULL
74	NULL
,	NULL
87	NULL
,	NULL
88	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
HTLV-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
and	NULL
immortalize	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
polyclonal	NULL
proliferation	NULL
of	NULL
infected	NULL
cells	NULL
and	NULL
subsequent	NULL
oligoclonal	NULL
or	NULL
monoclo-nal	NULL
growth	NULL
(	NULL
26	NULL
,	NULL
43	NULL
)	NULL
.	NULL

HTLV-1	NULL
contains	NULL
no	NULL
known	NULL
cellular	NULL
proto-oncogene	NULL
,	NULL
and	NULL
because	NULL
there	NULL
is	NULL
no	NULL
preferential	NULL
site	NULL
of	NULL
integration	NULL
among	NULL
infected	NULL
individuals	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
in	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Building	NULL
41	NULL
,	NULL
Room	NULL
B403	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-5055	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
301	NULL
)	NULL
496-6201	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
301	NULL
)	NULL
496-4951	NULL
.	NULL

E-mail	NULL
:	NULL
bradyj	NULL
@	NULL
dced1.nci.nih.gov	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Institute	NULL
fiir	NULL
Zellbiologie	NULL
,	NULL
Abteilung	NULL
Molekular-biologie	NULL
,	NULL
Eberhard-Karls-Universitat	NULL
Tubingen	NULL
,	NULL
7206	NULL
Tubingen	NULL
,	NULL
Ger-many	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Dermatology	NULL
Research	NULL
,	NULL
George	NULL
Washington	NULL
Uni-versity	NULL
,	NULL
Washington	NULL
,	NULL
DC	NULL
20037	NULL
.	NULL

1236	NULL
sertional	NULL
mutagenesis	NULL
is	NULL
responsible	NULL
for	NULL
viral	NULL
transformation	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
the	NULL
viral	NULL
transcriptional	NULL
activator	NULL
Tax	NULL
contributes	NULL
to	NULL
the	NULL
development	NULL
of	NULL
disease	NULL
(	NULL
23	NULL
,	NULL
28	NULL
,	NULL
29	NULL
,	NULL
82	NULL
)	NULL
.	NULL

Tax	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
viral	NULL
replication	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
48	NULL
,	NULL
86	NULL
)	NULL
,	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
transform	NULL
established	NULL
rodent	NULL
fibroblasts	NULL
to	NULL
anchorage-independent	NULL
growth	NULL
(	NULL
77	NULL
,	NULL
82	NULL
,	NULL
85	NULL
)	NULL
.	NULL

More-over	NULL
,	NULL
Tax	NULL
can	NULL
transform	NULL
primary	NULL
rat	NULL
embryo	NULL
fibroblasts	NULL
in	NULL
cooperation	NULL
with	NULL
activated	NULL
ras	NULL
(	NULL
67	NULL
)	NULL
as	NULL
well	NULL
as	NULL
immortalize	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
when	NULL
expressed	NULL
from	NULL
a	NULL
herpes	NULL
simplex	NULL
virus-based	NULL
vector	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
transgenic	NULL
mice	NULL
carrying	NULL
the	NULL
Tax	NULL
gene	NULL
frequently	NULL
develop	NULL
mesenchymal	NULL
tumors	NULL
and	NULL
neurofibromas	NULL
(	NULL
34	NULL
,	NULL
62	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
Tax	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
-associated	NULL
leukemogenesis	NULL
.	NULL

Tax	NULL
is	NULL
believed	NULL
to	NULL
exert	NULL
its	NULL
effect	NULL
by	NULL
stimulating	NULL
viral	NULL
gene	NULL
expression	NULL
and	NULL
by	NULL
deregulating	NULL
expression	NULL
of	NULL
cellular	NULL
genes	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
48	NULL
,	NULL
86	NULL
)	NULL
.	NULL

Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
proliferation	NULL
,	NULL
such	NULL
as	NULL
those	NULL
for	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
IL-2	NULL
,	NULL
the	NULL
IL-2	NULL
receptor	NULL
,	NULL
gran-ulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
parathyroid-related	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
I	NULL
(	NULL
see	NULL
references	NULL
22	NULL
,	NULL
23	NULL
,	NULL
48	NULL
,	NULL
and	NULL
86	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

The	NULL
aberrant	NULL
expression	NULL
of	NULL
these	NULL
growth-related	NULL
genes	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
contributing	NULL
to	NULL
the	NULL
establishment	NULL
of	NULL
HTLV-1-associated	NULL
pathogenesis	NULL
.	NULL

While	NULL
Tax	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
,	NULL
it	NULL
appears	NULL
to	NULL
stimulate	NULL
RNA	NULL
synthesis	NULL
through	NULL
protein-protein	NULL
interactions	NULL
with	NULL
host	NULL
cell	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
most	NULL
well	NULL
studied	NULL
of	NULL
these	NULL
interactions	NULL
is	NULL
with	NULL
the	NULL
ATF/CREB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
cyclic	NULL
AMP	NULL
-responsive	NULL
elements	NULL
in	NULL
the	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeats	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
22	NULL
,	NULL
24	NULL
,	NULL
66	NULL
,	NULL
81	NULL
,	NULL
83	NULL
,	NULL
91	NULL
)	NULL
.	NULL

Tax	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
transcription	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
genes	NULL
through	NULL
interaction	NULL
with	NULL
NF-	NULL
B-like	NULL
factors	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
serum	NULL
response	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
factor	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
36	NULL
,	NULL
48	NULL
,	NULL
61	NULL
,	NULL
86	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
steps	NULL
leading	NULL
to	NULL
the	NULL
deregulated	NULL
expression	NULL
of	NULL
cellular	NULL
genes	NULL
by	NULL
Tax	NULL
are	NULL
not	NULL
yet	NULL
understood	NULL
;	NULL
however	NULL
,	NULL
recent	NULL
reports	NULL
suggest	NULL
that	NULL
Tax	NULL
may	NULL
activate	NULL
transcription	NULL
through	NULL
enhancement	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
24	NULL
,	NULL
56	NULL
,	NULL
83	NULL
,	NULL
91	NULL
)	NULL
.	NULL

This	NULL
Tax-dependent	NULL
enhancement	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
in	NULL
part	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
basic	NULL
leucine	NULL
zipper	NULL
protein	NULL
dimerization	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
83	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
cellular	NULL
genes	NULL
which	NULL
contain	NULL
NF-kB	NULL
sites	NULL
by	NULL
increasing	NULL
the	NULL
nuclear	NULL
concentration	NULL
of	NULL
active	NULL
NF-kB	NULL
complexes	NULL
through	NULL
protein	NULL
translocation	NULL
(	NULL
36	NULL
,	NULL
57	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
critical	NULL
role	NULL
that	NULL
Tax	NULL
has	NULL
in	NULL
HTLV-1	NULL
patho-genesis	NULL
,	NULL
we	NULL
utilized	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
to	NULL
identify	NULL
cellular	NULL
proteins	NULL
which	NULL
interact	NULL
with	NULL
Tax	NULL
.	NULL

Our	NULL
studies	NULL
clearly	NULL
demonstrate	NULL
that	NULL
Tax	NULL
interacts	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
NF-Y	NULL
.	NULL

NF-Y	NULL
is	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
heteromeric	NULL
DNA	NULL
binding	NULL
protein	NULL
composed	NULL
of	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
subunits	NULL
(	NULL
52	NULL
,	NULL
76	NULL
)	NULL
.	NULL

NF-Y	NULL
(	NULL
also	NULL
called	NULL
CP-1	NULL
,	NULL
CBF	NULL
,	NULL
or	NULL
YEBP	NULL
)	NULL
recognizes	NULL
the	NULL
CCAAT	NULL
motif	NULL
and	NULL
was	NULL
initially	NULL
identified	NULL
by	NULL
its	NULL
binding	NULL
to	NULL
Y	NULL
boxes	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoters	NULL
(	NULL
20	NULL
,	NULL
89	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
the	NULL
B	NULL
subunit	NULL
of	NULL
NF-Y	NULL
directly	NULL
interacts	NULL
with	NULL
Tax	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
results	NULL
in	NULL
an	NULL
activation	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
.	NULL

Activation	NULL
of	NULL
NF-Y	NULL
by	NULL
Tax	NULL
may	NULL
also	NULL
increase	NULL
expression	NULL
of	NULL
other	NULL
cellular	NULL
genes	NULL
which	NULL
contribute	NULL
to	NULL
HTLV-1	NULL
induced	NULL
pathogenesis	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
cDNA	NULL
library	NULL
and	NULL
DNA	NULL
binding	NULL
domain	NULL
plasmids	NULL
.	NULL

HeLa	NULL
cDNA	NULL
library-en-coded	NULL
proteins	NULL
were	NULL
expressed	NULL
by	NULL
using	NULL
the	NULL
2m	NULL
TRPZ	NULL
galactose-inducible	NULL
pJG4-5	NULL
vector	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Roger	NULL
Brent	NULL
)	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
sequences	NULL
coding	NULL
for	NULL
the	NULL
influenza	NULL
virus	NULL
hemagglutinin	NULL
epitope	NULL
tag	NULL
,	NULL
the	NULL
B42	NULL
acidic	NULL
activation	NULL
domain	NULL
,	NULL
and	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
nuclear	NULL
localization	NULL
signal	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
cDNA	NULL
(	NULL
90	NULL
)	NULL
.	NULL

Tax	NULL
genes	NULL
(	NULL
wild	NULL
type	NULL
,	NULL
M7	NULL
,	NULL
M22	NULL
,	NULL
and	NULL
M47	NULL
)	NULL
were	NULL
cloned	NULL
downstream	NULL
from	NULL
the	NULL
DNA	NULL
binding	NULL
dimerization	NULL
domains	NULL
of	NULL
the	NULL
LexA	NULL
bacterial	NULL
repressor	NULL
in	NULL
the	NULL
Zam	NULL
£H/S3	NULL
vector	NULL
pL202PI	NULL
.	NULL

pL202PI-based	NULL
vectors	NULL
expressing	NULL
the	NULL
Tat	NULL
,	NULL
E6	NULL
,	NULL
or	NULL
Bicoid	NULL
protein	NULL
were	NULL
also	NULL
used	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Two-hybrid	NULL
assay	NULL
.	NULL

EGY48	NULL
(	NULL
MATa	NULL
tpl	NULL
ura3	NULL
his3	NULL
LEU2	NULL
:	NULL
pLexAop6-LEU2	NULL
)	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Roger	NULL
Brent	NULL
)	NULL
carrying	NULL
pJK103	NULL
(	NULL
URA3	NULL
)	NULL
,	NULL
which	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
GAL	NULL
1-lacZ	NULL
gene	NULL
from	NULL
two	NULL
high-affinity	NULL
ColE1	NULL
LexA	NULL
operators	NULL
(	NULL
90	NULL
)	NULL
,	NULL
was	NULL
transformed	NULL
with	NULL
pLexA/Tax	NULL
or	NULL
pLexA/M16	NULL
.	NULL

The	NULL
resulting	NULL
strains	NULL
were	NULL
transformed	NULL
with	NULL
the	NULL
pJG4-5-based	NULL
HeLa	NULL
library	NULL
(	NULL
TRP7	NULL
)	NULL
by	NULL
the	NULL
lithium	NULL
acetate	NULL
method	NULL
of	NULL
Ito	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
8.5	NULL
X	NULL
10°	NULL
primary	NULL
transformants	NULL
were	NULL
selected	NULL
on	NULL
Ura~	NULL
His~	NULL
Trp~	NULL
glucose	NULL
plates	NULL
,	NULL
scraped	NULL
,	NULL
and	NULL
pooled	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
x	NULL
10°	NULL
)	NULL
from	NULL
this	NULL
pool	NULL
were	NULL
spread	NULL
on	NULL
four	NULL
Ura	NULL
:	NULL
His	NULL
:	NULL
Trp	NULL
Leu~	NULL
galactose	NULL
plates	NULL
.	NULL

Colonies	NULL
appearing	NULL
3	NULL
days	NULL
later	NULL
were	NULL
streaked	NULL
onto	NULL
Ura	NULL
``	NULL
His	NULL
Trp	NULL
glucose	NULL
plates	NULL
and	NULL
Ura~	NULL
His~	NULL
Trp	NULL
Leu_	NULL
X-Gal	NULL
(	NULL
5-bromo-4-chloro-3-indolyl-B-p-galac-topyranoside	NULL
)	NULL
galactose	NULL
plates	NULL
.	NULL

Plasmids	NULL
from	NULL
blue	NULL
,	NULL
Leu*	NULL
colonies	NULL
were	NULL
recovered	NULL
by	NULL
direct	NULL
introduction	NULL
into	NULL
the	NULL
Escherichia	NULL
coli	NULL
K-12	NULL
strain	NULL
KCS	NULL
pyrF	NULL
:	NULL
:	NULL
Tn5	NULL
hsdR	NULL
1euB600	NULL
trpC9830	NULL
lacD74	NULL
strA	NULL
galK	NULL
hisB436	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
by	NULL
Marcil	NULL
and	NULL
Higgins	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
clones	NULL
were	NULL
sorted	NULL
into	NULL
a	NULL
total	NULL
of	NULL
12	NULL
classes	NULL
based	NULL
on	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
patterns	NULL
.	NULL

At	NULL
least	NULL
one	NULL
representative	NULL
cDNA	NULL
from	NULL
each	NULL
class	NULL
was	NULL
partially	NULL
sequenced	NULL
to	NULL
establish	NULL
identity	NULL
by	NULL
using	NULL
the	NULL
Sequenase	NULL
system	NULL
(	NULL
U.S.	NULL
Biochemicals	NULL
)	NULL
.	NULL

Two	NULL
identical	NULL
,	NULL
independently	NULL
isolated	NULL
,	NULL
full-length	NULL
NF-YB	NULL
clones	NULL
were	NULL
recovered	NULL
.	NULL

B-Galactosidase	NULL
assays	NULL
.	NULL

Quantitative	NULL
B-galactosidase	NULL
assays	NULL
with	NULL
o-nitrophe-nyl-B-p-galactosidase	NULL
were	NULL
performed	NULL
on	NULL
permeabilized	NULL
cells	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Ausubel	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
pJG4-5	NULL
Gall	NULL
promoter	NULL
was	NULL
induced	NULL
by	NULL
shaking	NULL
cultures	NULL
overnight	NULL
in	NULL
Ura	NULL
Trp	NULL
His~	NULL
Leu~	NULL
galactose	NULL
medium	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
ultrapure	NULL
water	NULL
and	NULL
suspended	NULL
to	NULL
an	NULL
optical	NULL
density	NULL
at	NULL
600	NULL
nm	NULL
of	NULL
0.2/ml	NULL
in	NULL
buffer	NULL
Z	NULL
(	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
MgSO	NULL
,	NULL
,	NULL
60	NULL
mM	NULL
Na	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
40	NULL
mM	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
1.0	NULL
ml	NULL
)	NULL
were	NULL
permeabilized	NULL
by	NULL
addition	NULL
of	NULL
15	NULL
pl	NULL
of	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
and	NULL
20	NULL
pl	NULL
of	NULL
chloroform	NULL
followed	NULL
by	NULL
a	NULL
10-s	NULL
vortex	NULL
.	NULL

After	NULL
incubation	NULL
of	NULL
the	NULL
samples	NULL
at	NULL
30°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
0.2	NULL
ml	NULL
of	NULL
o-nitrophenyl-B-p-galactoside	NULL
(	NULL
4	NULL
mg/ml	NULL
!	NULL

in	NULL
buffer	NULL
Z	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
incubation	NULL
at	NULL
30°C	NULL
was	NULL
continued	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
addition	NULL
of	NULL
0.5	NULL
ml	NULL
of	NULL
1	NULL
M	NULL
Na	NULL
,	NULL
COs	NULL
;	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
and	NULL
the	NULL
optical	NULL
density	NULL
at	NULL
420	NULL
nm	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
determined	NULL
.	NULL

Cell	NULL
lines	NULL
and	NULL
nuclear	NULL
extracts	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
to	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
100	NULL
mM	NULL
glutamine	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
72	NULL
)	NULL
from	NULL
Jurkat	NULL
and	NULL
CEM	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
T-cell	NULL
lines	NULL
,	NULL
as	NULL
well	NULL
as	NULL
from	NULL
the	NULL
HTLV-1-transformed	NULL
cell	NULL
lines	NULL
C81	NULL
and	NULL
MT2	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
suspended	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
100	NULL
wM	NULL
EDTA	NULL
,	NULL
100	NULL
wM	NULL
EGTA	NULL
,	NULL
500	NULL
wM	NULL
INTERACTION	NULL
OF	NULL
HTLV-1	NULL
Tax	NULL
AND	NULL
CCAAT	NULL
BINDING	NULL
PROTEIN	NULL
NF-Y	NULL
-	NULL
1237	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
)	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
cells	NULL
per	NULL
400	NULL
pl	NULL
.	NULL

After	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
Nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.6	NULL
%	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
vortexed	NULL
for	NULL
10	NULL
s.	NULL
Nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
s	NULL
at	NULL
room	NULL
temper-ature	NULL
.	NULL

The	NULL
pellets	NULL
were	NULL
suspended	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
and	NULL
rocked	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
to	NULL
extract	NULL
proteins	NULL
.	NULL

Extracts	NULL
were	NULL
centrifuged	NULL
(	NULL
10,000	NULL
x	NULL
g	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
transferred	NULL
to	NULL
new	NULL
tubes	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Protein	NULL
analysis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
300	NULL
mg	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
either	NULL
NF-YA	NULL
antibody	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
or	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
antibody	NULL
(	NULL
10	NULL
mg	NULL
)	NULL
of	NULL
the	NULL
same	NULL
isotype	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
pl	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
to	NULL
capture	NULL
antibody-protein	NULL
complexes	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
wash	NULL
buffer	NULL
(	NULL
120	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
200	NULL
uM	NULL
sodium	NULL
vanadate	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
50	NULL
mM	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
with	NULL
1	NULL
ag	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
and	NULL
18	NULL
g	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
beads	NULL
by	NULL
boiling	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
and	NULL
separated	NULL
in	NULL
4	NULL
to	NULL
20	NULL
%	NULL
polyacrylamide	NULL
Tris-glycine	NULL
gels	NULL
(	NULL
Novex	NULL
)	NULL
.	NULL

Fifty	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
run	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
as	NULL
described	NULL
by	NULL
Ausubel	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
Tax	NULL
(	NULL
14	NULL
)	NULL
,	NULL
NF-YA	NULL
(	NULL
Rockland	NULL
Inc.	NULL
)	NULL
,	NULL
or	NULL
NF-¥B	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Robert	NULL
Mantovani	NULL
)	NULL
and	NULL
visualized	NULL
by	NULL
chemilumi-nescence	NULL
(	NULL
Amersham	NULL
}	NULL
.	NULL

GST	NULL
binding	NULL
assay	NULL
.	NULL

Five	NULL
hundred	NULL
nanograms	NULL
of	NULL
purified	NULL
glutathione	NULL
S-trans-ferase	NULL
(	NULL
GST	NULL
)	NULL
or	NULL
GST-Tax	NULL
was	NULL
incubated	NULL
with	NULL
30	NULL
pl	NULL
of	NULL
a	NULL
50	NULL
%	NULL
slurry	NULL
of	NULL
glutathione-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
to	NULL
remove	NULL
unbound	NULL
proteins	NULL
and	NULL
suspended	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
.	NULL

Radiolabeled	NULL
NF-YA	NULL
,	NULL
NF-YB	NULL
,	NULL
and	NULL
YB-1	NULL
proteins	NULL
were	NULL
synthesized	NULL
in	NULL
vitro	NULL
by	NULL
using	NULL
the	NULL
TNT	NULL
T7-coupled	NULL
rabbit	NULL
reticulo-cyte	NULL
lysate	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
radiolabeled	NULL
with	NULL
40	NULL
Ci	NULL
of	NULL
(	NULL
>	NULL
1,000	NULL
Ci/mmol	NULL
)	NULL
(	NULL
Amersham	NULL
)	NULL
in	NULL
a	NULL
50-pl	NULL
volume	NULL
.	NULL

The	NULL
in	NULL
vitro-translated	NULL
mixtures	NULL
(	NULL
5	NULL
pl	NULL
)	NULL
were	NULL
added	NULL
to	NULL
either	NULL
GST	NULL
or	NULL
GST-Tax	NULL
coupled	NULL
to	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
rotated	NULL
at	NULL
4°C	NULL
for	NULL
3	NULL
h	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
binding	NULL
buffer	NULL
plus	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
beads	NULL
by	NULL
boiling	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
electro-phoresis	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide-SDS	NULL
gels	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

mRNAs	NULL
from	NULL
human	NULL
T-cell	NULL
lines	NULL
and	NULL
an	NULL
osteosarcoma	NULL
cell	NULL
line	NULL
were	NULL
prepared	NULL
and	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
as	NULL
described	NULL
by	NULL
Dittmer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
.	NULL

Gel-purified	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
DQB	NULL
[	NULL
5'-GGTCGTG	NULL
CGGAGCTCCAACTGGTAGTTGTGTCTGCACACCGTGTCCA-3	NULL
'	NULL
and	NULL
NE-YB	NULL
[	NULL
5-CCGTTTCTCTTGATGGCACCTTTCACTTGC-3	NULL
'	NULL
]	NULL
)	NULL
were	NULL
end	NULL
labeled	NULL
by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
dATP	NULL
(	NULL
>	NULL
3,000	NULL
Ci/mmol	NULL
!	NULL
)	NULL

as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Electroporations	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Jurkat	NULL
cells	NULL
cultured	NULL
to	NULL
a	NULL
density	NULL
of	NULL
1	NULL
x	NULL
10°	NULL
cells/ml	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
and	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
at	NULL
2.5	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

DNA	NULL
diluted	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
distilled	NULL
water	NULL
was	NULL
added	NULL
to	NULL
250	NULL
pl	NULL
of	NULL
cells	NULL
and	NULL
electroporated	NULL
with	NULL
the	NULL
Gibco	NULL
BRL	NULL
Cell	NULL
Porator	NULL
Electroporation	NULL
System	NULL
at	NULL
250	NULL
V	NULL
and	NULL
800	NULL
pF	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
chilled	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
and	NULL
suspended	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
24	NULL
to	NULL
36	NULL
h	NULL
posttransfection	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
suspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
0.25	NULL
M	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
subjected	NULL
to	NULL
three	NULL
cycles	NULL
of	NULL
freezing-thawing	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Conversion	NULL
was	NULL
quantitated	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
.	NULL

All	NULL
other	NULL
promoter	NULL
constructs	NULL
were	NULL
derived	NULL
from	NULL
pDQBCAT	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Elliot	NULL
P.	NULL
Cowan	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
DQB	NULL
promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
pBLCAT3	NULL
(	NULL
50	NULL
)	NULL
.	NULL

pAH/PCAT	NULL
,	NULL
which	NULL
lacks	NULL
promoter	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
Y	NULL
box	NULL
,	NULL
was	NULL
designed	NULL
by	NULL
deletion	NULL
of	NULL
the	NULL
internal	NULL
HindIII-to-PpuMI	NULL
restriction	NULL
fragment	NULL
.	NULL

pAB/PCAT	NULL
with	NULL
the	NULL
Y	NULL
box	NULL
deleted	NULL
was	NULL
constructed	NULL
by	NULL
digestion	NULL
of	NULL
pDQBCAT	NULL
with	NULL
PpuMI	NULL
and	NULL
BsmFI	NULL
,	NULL
and	NULL
restriction	NULL
sites	NULL
were	NULL
blunt	NULL
ended	NULL
with	NULL
mung	NULL
bean	NULL
nuclease	NULL
prior	NULL
to	NULL
ligation	NULL
.	NULL

The	NULL
Y-box	NULL
mutant	NULL
pBclICAT	NULL
was	NULL
constructed	NULL
by	NULL
digesting	NULL
pDQBCAT	NULL
with	NULL
BsmFI	NULL
and	NULL
PpuMI	NULL
and	NULL
ligating	NULL
the	NULL
complementary	NULL
oligonucleotide	NULL
5	NULL
-GTCCTTCAGCTCCAGTGCTGATCATTIT	NULL
CTTTTCCGAGGGACCATCCAATCC-3	NULL
'	NULL
.	NULL

All	NULL
mutant	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
restriction	NULL
digestion	NULL
and	NULL
sequence	NULL
analysis	NULL
.	NULL

Gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
gel-purified	NULL
oligonucleotide	NULL
5'-TCCAGTGCTGATIGGTTITTCCGAGGGA-3	NULL
'	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
Y-box	NULL
element	NULL
,	NULL
was	NULL
end	NULL
labeled	NULL
by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-	NULL
>	NULL
°P	NULL
]	NULL
dATP	NULL
(	NULL
>	NULL
3,000	NULL
Ci/mmol	NULL
!	NULL
)	NULL

and	NULL
made	NULL
double	NULL
stranded	NULL
by	NULL
annealing	NULL
to	NULL
100	NULL
ng	NULL
of	NULL
the	NULL
gel-purified	NULL
antisense	NULL
oligonucleotide	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
6	NULL
ug	NULL
)	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
unlabeled	NULL
competitor	NULL
DNA	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
antibody	NULL
in	NULL
(	NULL
final	NULL
concentrations	NULL
)	NULL
12.5	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-6.25	NULL
mM	NULL
MgC1	NULL
,	NULL
-0.05	NULL
%	NULL
NP-40-5	NULL
mM	NULL
ZnS	NULL
$	NULL
O	NULL
,	NULL
-50	NULL
mM	NULL
KC-50	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml-10	NULL
%	NULL
glycerol	NULL
.	NULL

Following	NULL
preincu-bation	NULL
,	NULL
100	NULL
pg	NULL
(	NULL
4,000	NULL
cpm	NULL
)	NULL
of	NULL
radiolabeled	NULL
DNA	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
to	NULL
30	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
electrophoresed	NULL
on	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
containing	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
and	NULL
0.05	NULL
%	NULL
NP-40	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
quantitated	NULL
with	NULL
the	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
.	NULL

1238	NULL
PISE-MASISON	NULL
ET	NULL
AL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

B-Galactosidase	NULL
activities	NULL
of	NULL
NF-YB-expressing	NULL
strains	NULL
DNA	NULL
binding	NULL
Activator	NULL
B-Galactosidase	NULL
Fold	NULL
(	NULL
LexA	NULL
)	NULL
fusion	NULL
fusion	NULL
activity	NULL
``	NULL
(	NULL
U	NULL
)	NULL
increase	NULL
``	NULL
NF-YB	NULL
Vector	NULL
7.1	NULL
#	NULL
1.7	NULL
Tax	NULL
304	NULL
+	NULL
17.3	NULL
42.8	NULL
Tax	NULL
Vector	NULL
17.3	NULL
+	NULL
2.4	NULL
NF-YB	NULL
458	NULL
+	NULL
19.5	NULL
26.5	NULL
Tax	NULL
M7	NULL
(	NULL
°CP-AS	NULL
)	NULL
Vector	NULL
6.8	NULL
+	NULL
1.8	NULL
NF-YB	NULL
5.3	NULL
+	NULL
1.6	NULL
0.8	NULL
Tax	NULL
M22	NULL
(	NULL
°TL-AS	NULL
)	NULL
Vector	NULL
15.9	NULL
+	NULL
3.8	NULL
NF-YB	NULL
693	NULL
+	NULL
17.6	NULL
43.6	NULL
Tax	NULL
M47	NULL
(	NULL
P'°LL-RS	NULL
)	NULL
Vector	NULL
18.6	NULL
+	NULL
2.9	NULL
NF-YB	NULL
438	NULL
+	NULL
22.5	NULL
23.5	NULL
Bicoid	NULL
Vector	NULL
18.2	NULL
+	NULL
1.5	NULL
NF-YB	NULL
18.2	NULL
+	NULL
1.0	NULL
1.0	NULL
Tat	NULL
Vector	NULL
7.7	NULL
*	NULL
2.2	NULL
NF-YB	NULL
4.7	NULL
#	NULL
1.7	NULL
0.6	NULL
E6	NULL
Vector	NULL
14.9	NULL
+	NULL
1.0	NULL
NF-YB	NULL
16.0	NULL
+	NULL
.73	NULL
1.1	NULL
*	NULL
The	NULL
B-galactosidase	NULL
activities	NULL
of	NULL
four	NULL
independent	NULL
clones	NULL
for	NULL
each	NULL
strain	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

*	NULL
Fold	NULL
increase	NULL
in	NULL
activity	NULL
compared	NULL
with	NULL
vector	NULL
control	NULL
.	NULL

RESULTS	NULL
Isolation	NULL
of	NULL
NF-YB	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
library	NULL
screen	NULL
.	NULL

Tax	NULL
,	NULL
expressed	NULL
as	NULL
a	NULL
fusion	NULL
to	NULL
LexA	NULL
,	NULL
was	NULL
used	NULL
as	NULL
bait	NULL
to	NULL
screen	NULL
a	NULL
conditionally	NULL
expressed	NULL
cDNA	NULL
library	NULL
by	NULL
using	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
.	NULL

Two	NULL
identical	NULL
independent	NULL
clones	NULL
of	NULL
the	NULL
B	NULL
subunit	NULL
of	NULL
the	NULL
human	NULL
CCAAT	NULL
binding	NULL
protein	NULL
NF-Y	NULL
were	NULL
isolated	NULL
and	NULL
chosen	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
NF-YB-Tax	NULL
interaction	NULL
by	NULL
testing	NULL
the	NULL
ability	NULL
of	NULL
NF-YB	NULL
fused	NULL
to	NULL
an	NULL
acidic	NULL
activation	NULL
domain	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
different	NULL
LexA	NULL
fusion	NULL
proteins	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

A	NULL
27-fold	NULL
increase	NULL
over	NULL
background	NULL
B-galactosidase	NULL
activity	NULL
was	NULL
produced	NULL
in	NULL
strains	NULL
which	NULL
contained	NULL
LexA-Tax	NULL
and	NULL
NF-YB	NULL
.	NULL

In	NULL
reciprocal	NULL
assays	NULL
in	NULL
which	NULL
NF-YB	NULL
was	NULL
expressed	NULL
as	NULL
the	NULL
bait	NULL
and	NULL
Tax	NULL
was	NULL
expressed	NULL
as	NULL
the	NULL
prey	NULL
,	NULL
B-galactosidase	NULL
levels	NULL
were	NULL
43-fold	NULL
above	NULL
the	NULL
background	NULL
level	NULL
,	NULL
supporting	NULL
the	NULL
initial	NULL
observation	NULL
of	NULL
Tax-NF-YB	NULL
interaction	NULL
.	NULL

M22	NULL
(	NULL
°°TL-AS	NULL
)	NULL
and	NULL
M47	NULL
(	NULL
@	NULL
*°LL-RS	NULL
)	NULL
,	NULL
mutant	NULL
derivatives	NULL
of	NULL
Tax	NULL
that	NULL
have	NULL
differential	NULL
abilities	NULL
to	NULL
activate	NULL
the	NULL
HTLV-1	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
long	NULL
terminal	NULL
repeats	NULL
(	NULL
78	NULL
)	NULL
,	NULL
interact	NULL
with	NULL
NF-YB	NULL
at	NULL
levels	NULL
equivalent	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
what	NULL
is	NULL
observed	NULL
with	NULL
wild-type	NULL
Tax	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

NF-YB	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
LexA	NULL
or	NULL
with	NULL
the	NULL
transactivators	NULL
Bicoid	NULL
,	NULL
Tat	NULL
,	NULL
and	NULL
E6	NULL
.	NULL

Interestingly	NULL
,	NULL
NF-YB	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
Tax	NULL
mutant	NULL
M7	NULL
(	NULL
?	NULL

°CP-AS	NULL
)	NULL
(	NULL
78	NULL
)	NULL
,	NULL
which	NULL
is	NULL
defective	NULL
in	NULL
activating	NULL
transcription	NULL
from	NULL
the	NULL
HTLV-1	NULL
or	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeats	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
M7	NULL
mutation	NULL
does	NULL
not	NULL
allow	NULL
Tax	NULL
to	NULL
localize	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
LexA	NULL
DNA	NULL
binding	NULL
domain	NULL
this	NULL
mutant	NULL
was	NULL
able	NULL
to	NULL
enter	NULL
the	NULL
nucleus	NULL
as	NULL
determined	NULL
by	NULL
repression	NULL
assays	NULL
(	NULL
6	NULL
)	NULL
and	NULL
thus	NULL
to	NULL
provide	NULL
information	NULL
on	NULL
Tax-NF-YB	NULL
interaction	NULL
.	NULL

Together	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
NF-YB	NULL
specifically	NULL
interacts	NULL
with	NULL
Tax	NULL
in	NULL
the	NULL
two-hybrid	NULL
system	NULL
.	NULL

Interaction	NULL
of	NULL
Tax	NULL
with	NULL
NF-YB	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
NF-YB	NULL
through	NULL
capture	NULL
by	NULL
GST-Tax	NULL
fusion	NULL
proteins	NULL
.	NULL

In	NULL
vitro-synthesized	NULL
NF-YA	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
,	NULL
NF-YB	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
YB-1	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
purified	NULL
GST	NULL
or	NULL
GST-Tax	NULL
proteins	NULL
bound	NULL
to	NULL
glutathione-Sepharose	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

GST	NULL
-Tax	NULL
,	NULL
but	NULL
not	NULL
GST	NULL
,	NULL
allowed	NULL
the	NULL
efficient	NULL
capture	NULL
(	NULL
15	NULL
%	NULL
)	NULL
of	NULL
NF-YB	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
transcription	NULL
factor	NULL
YB-1	NULL
,	NULL
which	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
Y	NULL
box	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
(	NULL
58	NULL
,	NULL
68	NULL
,	NULL
70	NULL
,	NULL
84	NULL
)	NULL
,	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
either	NULL
GST	NULL
or	NULL
GST-Tax	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
A	NULL
subunit	NULL
of	NULL
NF-Y	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
also	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
GST-Tax	NULL
over	NULL
background	NULL
GST	NULL
binding	NULL
,	NULL
demonstrating	NULL
specificity	NULL
of	NULL
Tax-NF-YB	NULL
interaction	NULL
.	NULL

We	NULL
next	NULL
analyzed	NULL
the	NULL
intracellular	NULL
association	NULL
of	NULL
NF-YB	NULL
and	NULL
Tax	NULL
by	NULL
coimmunoprecipitation	NULL
analysis	NULL
with	NULL
Tax-expressing	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
from	NULL
both	NULL
Jurkat	NULL
and	NULL
C81	NULL
(	NULL
HTLV-1-transformed	NULL
)	NULL
T-cell	NULL
lines	NULL
.	NULL

Although	NULL
C81	NULL
cells	NULL
do	NULL
not	NULL
produce	NULL
virus	NULL
,	NULL
they	NULL
constitutively	NULL
express	NULL
Tax	NULL
protein	NULL
from	NULL
an	NULL
integrated	NULL
copy	NULL
of	NULL
the	NULL
HTLV-1	NULL
genome	NULL
.	NULL

The	NULL
relative	NULL
amounts	NULL
of	NULL
NF-YA	NULL
,	NULL
NF-YB	NULL
,	NULL
and	NULL
Tax	NULL
detected	NULL
in	NULL
50	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

NF-YA	NULL
and	NULL
NF-YB	NULL
proteins	NULL
are	NULL
detected	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
NF-Y	NULL
protein	NULL
levels	NULL
appear	NULL
to	NULL
be	NULL
slightly	NULL
higher	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
C81	NULL
cells	NULL
.	NULL

Tax	NULL
is	NULL
detected	NULL
only	NULL
in	NULL
C81	NULL
cells	NULL
,	NULL
and	NULL
equivalent	NULL
levels	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
factor	NULL
Spl	NULL
are	NULL
detected	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

Antibodies	NULL
directed	NULL
against	NULL
the	NULL
NF-YA	NULL
subunit	NULL
were	NULL
used	NULL
for	NULL
testing	NULL
the	NULL
Tax-NF-YB	NULL
interaction	NULL
in	NULL
vivo	NULL
since	NULL
the	NULL
antibody	NULL
to	NULL
NF-YB	NULL
fails	NULL
to	NULL
immunopre-cipitate	NULL
NF-Y	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
immunoprecipitated	NULL
with	NULL
NF-	NULL
YA	NULL
antibody	NULL
coprecipitated	NULL
Tax	NULL
,	NULL
while	NULL
a	NULL
control	NULL
IgG	NULL
antibody	NULL
of	NULL
the	NULL
same	NULL
isotype	NULL
failed	NULL
to	NULL
coprecipitate	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
NF-YA	NULL
antibody	NULL
did	NULL
not	NULL
cross-react	NULL
with	NULL
Tax	NULL
,	NULL
indicating	NULL
that	NULL
Tax	NULL
is	NULL
not	NULL
directly	NULL
immunoprecipitated	NULL
by	NULL
anti-NF-YA	NULL
.	NULL

These	NULL
same	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
HTLV-1-transformed	NULL
cell	NULL
line	NULL
MT2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NF-Y-Tax	NULL
complexes	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
when	NULL
anti-Tax	NULL
antibodies	NULL
were	NULL
used	NULL
.	NULL

However	NULL
,	NULL
this	NULL
may	NULL
be	NULL
due	NULL
to	NULL
disruption	NULL
of	NULL
the	NULL
complex	NULL
upon	NULL
antibody	NULL
binding	NULL
,	NULL
or	NULL
the	NULL
antibodies	NULL
we	NULL
have	NULL
used	NULL
may	NULL
block	NULL
the	NULL
interaction	NULL
.	NULL

Since	NULL
we	NULL
observed	NULL
an	NULL
interaction	NULL
with	NULL
Tax	NULL
and	NULL
NF-YB	NULL
in	NULL
the	NULL
two-hybrid	NULL
and	NULL
GST	NULL
binding	NULL
assays	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
the	NULL
NF-Y	NULL
complex	NULL
by	NULL
coimmunoprecipitation	NULL
is	NULL
probably	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
NF-YB	NULL
subunit	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
the	NULL
A	NULL
subunit	NULL
of	NULL
NF-Y	NULL
,	NULL
although	NULL
present	NULL
in	NULL
our	NULL
cDNA	NULL
library	NULL
as	NULL
determined	NULL
by	NULL
PCR	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
was	NULL
not	NULL
identified	NULL
in	NULL
the	NULL
interactive	NULL
screen	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NF-YA	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
GST-Tax	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
Tax	NULL
A	NULL
.	NULL

20	NULL
%	NULL
Input	NULL
NF-YB	NULL
___	NULL
YB-41	NULL
___	NULL
NFYA	NULL
B	NULL
I	NULL
1	NULL
OC	NULL
1T	NULL
1	NULL
1	NULL
1	NULL
sos	NULL
c	NULL
``	NULL
250	NULL
:	NULL
&	NULL
l	NULL
a	NULL
5	NULL
b	NULL
b	NULL
b	NULL
b	NULL
@	NULL
5	NULL
i	NULL
Z	NULL
2	NULL
>	NULL
0	NULL
O	NULL
o	NULL
O	NULL
0	NULL
0	NULL
0	NULL
0	NULL
220k	NULL
97	NULL
.	NULL

4k	NULL
66k	NULL
-	NULL
re-46K	NULL
waaay	NULL
,	NULL
30k	NULL
«	NULL
mu	NULL
»	NULL
1	NULL
2	NULL
3	NULL
40	NULL
50	NULL
6	NULL
70	NULL
8	NULL
9	NULL
1	NULL
2	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

NF-YB	NULL
binds	NULL
to	NULL
GST-TAX	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Radiolabeled	NULL
,	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
(	NULL
NF-YA	NULL
,	NULL
NF-YB	NULL
,	NULL
and	NULL
YB-1	NULL
)	NULL
were	NULL
coprecipitated	NULL
with	NULL
GST	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
GST-TAX	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

The	NULL
translated	NULL
proteins	NULL
retained	NULL
on	NULL
the	NULL
glutathione-Sepharose	NULL
matrix	NULL
were	NULL
resolved	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide-SDS	NULL
gels	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
contain	NULL
20	NULL
%	NULL
of	NULL
the	NULL
total	NULL
protein	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
assays	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Coomassie	NULL
blue-stained	NULL
10	NULL
%	NULL
polyacrylamide-SDS	NULL
gel	NULL
containing	NULL
500	NULL
ng	NULL
of	NULL
GST	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
GST-TAX	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
used	NULL
in	NULL
panel	NULL
A.	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
~	NULL
A.	NULL
tip	NULL
m	NULL
J	NULL
%	NULL
Y	NULL
-	NULL
G	NULL
owe	NULL
ﬁ—Tax	NULL
quem	NULL
.	NULL

<	NULL
-	NULL
NF-Y/A	NULL
<	NULL
-	NULL
NF-YB	NULL
aaa	NULL
ae	NULL
1	NULL
2	NULL
B	NULL
Jurkat	NULL
C81	NULL
x	NULL
x	NULL
'	NULL
©	NULL
°C	NULL
S2	NULL
$	NULL
o	NULL
$	NULL
3	NULL
&	NULL
$	NULL
&	NULL
§	NULL
©	NULL
$	NULL
o	NULL
dF	NULL
dé	NULL
97.4	NULL
66	NULL
-	NULL
us	NULL
46	NULL
-	NULL
suze	NULL
``	NULL
we	NULL
eng	NULL
*	NULL
30	NULL
-	NULL
<	NULL
-	NULL
Tax	NULL
21.5	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Tax	NULL
binds	NULL
to	NULL
NF-Y	NULL
in	NULL
HTLV-1-transformed	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
NF-YA	NULL
,	NULL
NF-YB	NULL
,	NULL
Tax	NULL
,	NULL
and	NULL
Sp1	NULL
(	NULL
used	NULL
as	NULL
a	NULL
loading	NULL
control	NULL
)	NULL
expressed	NULL
in	NULL
50	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
C81	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
T-cell	NULL
lines	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
extracts	NULL
(	NULL
300	NULL
ug	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
either	NULL
NF-YA	NULL
or	NULL
mouse	NULL
anti-rabbit	NULL
IgG	NULL
antibody	NULL
.	NULL

The	NULL
captured	NULL
proteins	NULL
were	NULL
compared	NULL
to	NULL
50	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
and	NULL
C81	NULL
cells	NULL
by	NULL
immunoblot	NULL
analysis	NULL
with	NULL
Tax	NULL
antibody	NULL
after	NULL
separation	NULL
on	NULL
4	NULL
to	NULL
20	NULL
%	NULL
polyacrylamide	NULL
Tris-glycine	NULL
gels	NULL
.	NULL

The	NULL
band	NULL
marked	NULL
with	NULL
an	NULL
asterisk	NULL
indicates	NULL
the	NULL
IgG	NULL
heavy	NULL
chain	NULL
.	NULL

Numbers	NULL
on	NULL
the	NULL
left	NULL
are	NULL
molecular	NULL
weights	NULL
in	NULL
thousands	NULL
.	NULL

coimmunoprecipitated	NULL
with	NULL
NF-YA	NULL
demonstrates	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
Tax	NULL
to	NULL
NF-YB	NULL
does	NULL
not	NULL
dissociate	NULL
NF-YB	NULL
from	NULL
the	NULL
NF-Y	NULL
heterotrimer	NULL
,	NULL
and	NULL
thus	NULL
the	NULL
complex	NULL
could	NULL
still	NULL
be	NULL
capable	NULL
of	NULL
binding	NULL
DNA	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
DQ	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
established	NULL
that	NULL
NF-Y	NULL
is	NULL
a	NULL
critical	NULL
factor	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
and	NULL
that	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
is	NULL
increased	NULL
in	NULL
HTLV-1-infected	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
25	NULL
,	NULL
38	NULL
,	NULL
47	NULL
,	NULL
51	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
what	NULL
effect	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
NF-Y	NULL
has	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Since	NULL
the	NULL
HTLV-1	NULL
activation	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
DQ	NULL
promoter	NULL
has	NULL
not	NULL
been	NULL
examined	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
,	NULL
we	NULL
first	NULL
determined	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
DQB	NULL
one	NULL
of	NULL
the	NULL
three	NULL
class	NULL
II	NULL
alleles	NULL
)	NULL
mRNA	NULL
from	NULL
T-cell	NULL
lines	NULL
which	NULL
were	NULL
either	NULL
HTLV-1	NULL
negative	NULL
(	NULL
Jurkat	NULL
and	NULL
CEM	NULL
)	NULL
or	NULL
HTLV-1	NULL
positive	NULL
(	NULL
HUT-102	NULL
,	NULL
MT-2	NULL
,	NULL
and	NULL
C81	NULL
)	NULL
.	NULL

A	NULL
dramatic	NULL
increase	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
transcription	NULL
was	NULL
seen	NULL
in	NULL
HTLV-1-transformed	NULL
cell	NULL
lines	NULL
compared	NULL
to	NULL
Jurkat	NULL
and	NULL
CEM	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
NF-YB	NULL
message	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
were	NULL
approximately	NULL
equal	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
examined	NULL
.	NULL

To	NULL
better	NULL
characterize	NULL
the	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
the	NULL
HLA-DQ	NULL
promoter	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
transactivate	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
DQB	NULL
promoters	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
by	NULL
using	NULL
transient-transfection	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Tax	NULL
caused	NULL
an	NULL
increase	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
wild-type	NULL
DQB	NULL
construct	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

When	NULL
the	NULL
mutant	NULL
constructs	NULL
were	NULL
compared	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Tax	NULL
expression	NULL
was	NULL
similar	NULL
in	NULL
each	NULL
promoter	NULL
construct	NULL
transfection	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
;	NULL
however	NULL
,	NULL
differences	NULL
in	NULL
CAT	NULL
activity	NULL
were	NULL
observed	NULL
.	NULL

Tax	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
expression	NULL
from	NULL
the	NULL
vector	NULL
alone	NULL
,	NULL
whereas	NULL
a	NULL
fivefold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
from	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
(	NULL
pDQCAT	NULL
)	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

A	NULL
threefold	NULL
increase	NULL
in	NULL
activity	NULL
was	NULL
seen	NULL
INTERACTION	NULL
OF	NULL
HTLV-1	NULL
Tax	NULL
AND	NULL
CCAAT	NULL
BINDING	NULL
PROTEIN	NULL
NF-Y	NULL
-	NULL
1239	NULL
when	NULL
the	NULL
Y-box	NULL
and	NULL
CCAAT	NULL
sequences	NULL
were	NULL
the	NULL
only	NULL
elements	NULL
directing	NULL
CAT	NULL
expression	NULL
(	NULL
pAH/PCAT	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
both	NULL
the	NULL
Y	NULL
box	NULL
and	NULL
the	NULL
CCAAT	NULL
element	NULL
(	NULL
pAB/PCAT	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
abolished	NULL
promoter	NULL
activity	NULL
.	NULL

When	NULL
we	NULL
mutated	NULL
the	NULL
Y	NULL
box	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
full-length	NULL
promoter	NULL
(	NULL
pBclICAT	NULL
)	NULL
,	NULL
the	NULL
basal	NULL
promoter	NULL
was	NULL
active	NULL
;	NULL
however	NULL
,	NULL
Tax-mediated	NULL
transactivation	NULL
was	NULL
abrogated	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
mutation	NULL
prevented	NULL
NF-Y	NULL
binding	NULL
to	NULL
the	NULL
Y	NULL
box	NULL
,	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lane	NULL
4	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Bcell	NULL
mutation	NULL
was	NULL
unable	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
wild-type	NULL
Y-box	NULL
element	NULL
for	NULL
NF-Y	NULL
binding	NULL
.	NULL

The	NULL
wild-type	NULL
Y-box	NULL
oligonucleotide	NULL
did	NULL
compete	NULL
for	NULL
NF-Y	NULL
binding	NULL
,	NULL
and	NULL
anti-NF-YA	NULL
antibody	NULL
supershifted	NULL
the	NULL
NF-Y	NULL
complex	NULL
to	NULL
the	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
Y	NULL
box	NULL
is	NULL
the	NULL
Tax-responsive	NULL
element	NULL
in	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
.	NULL

Tax	NULL
mutants	NULL
M22	NULL
and	NULL
M47	NULL
activated	NULL
transcription	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
the	NULL
two-hybrid	NULL
system	NULL
,	NULL
in	NULL
which	NULL
both	NULL
M22	NULL
and	NULL
M47	NULL
were	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
NF-YB	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
Tax	NULL
mutant	NULL
M22	NULL
is	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
CREB	NULL
and	NULL
thus	NULL
can	NULL
activate	NULL
CREB-driven	NULL
promoters	NULL
such	NULL
as	NULL
the	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

However	NULL
,	NULL
M22	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
,	NULL
unlike	NULL
wild-type	NULL
Tax	NULL
,	NULL
can	NULL
not	NULL
activate	NULL
NF-kB	NULL
promoters	NULL
(	NULL
78	NULL
)	NULL
.	NULL

The	NULL
M47	NULL
mutant	NULL
has	NULL
the	NULL
reverse	NULL
phenotype	NULL
from	NULL
that	NULL
of	NULL
M22	NULL
(	NULL
78	NULL
)	NULL
.	NULL

Since	NULL
M22	NULL
and	NULL
M47	NULL
are	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
DQB	NULL
promoter	NULL
,	NULL
these	NULL
data	NULL
argue	NULL
that	NULL
NF-kB	NULL
and	NULL
CREB	NULL
factors	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
.	NULL

Since	NULL
the	NULL
Tax	NULL
mutant	NULL
M7	NULL
does	NULL
not	NULL
localize	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
78	NULL
)	NULL
,	NULL
it	NULL
was	NULL
not	NULL
included	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
Tax	NULL
can	NULL
increase	NULL
expression	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
and	NULL
that	NULL
this	NULL
increase	NULL
is	NULL
a	NULL
consequence	NULL
of	NULL
its	NULL
interaction	NULL
with	NULL
NF-Y	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
demonstrated	NULL
that	NULL
Tax	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
CCAAT	NULL
binding	NULL
factor	NULL
NF-Y	NULL
and	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
DQB	NULL
gene	NULL
,	NULL
a	NULL
gene	NULL
involved	NULL
in	NULL
cellular	NULL
differentiation	NULL
and	NULL
activation	NULL
(	NULL
20	NULL
,	NULL
89	NULL
)	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
transcription	NULL
of	NULL
other	NULL
genes	NULL
involved	NULL
in	NULL
cellular	NULL
acti-	NULL
E	NULL
o	NULL
A	NULL
-	NULL
g.g8	NULL
,	NULL
<	NULL
4eCL	NULL
-~	NULL
$	NULL
832258	NULL
28	NULL
S	NULL
o	NULL
“	NULL
DQB	NULL
18S	NULL
B	NULL
.	NULL

@	NULL
w	NULL
-	NULL
@	NULL
a	NULL
=	NULL
_	NULL
NF-YB	NULL
C.	NULL
Actin	NULL
1	NULL
2	NULL
3	NULL
456	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
mRNA	NULL
.	NULL

mRNAs	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
from	NULL
OsA-CL	NULL
,	NULL
CEM	NULL
,	NULL
Jurkat	NULL
,	NULL
HUT102	NULL
,	NULL
MT-2	NULL
,	NULL
and	NULL
C81	NULL
cells	NULL
were	NULL
electrophoretically	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
blotted	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
sequentially	NULL
hybridized	NULL
with	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probes	NULL
specific	NULL
for	NULL
DQB	NULL
(	NULL
A	NULL
)	NULL
,	NULL
NF-YB	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
«	NULL
-actin	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
28	NULL
$	NULL
and	NULL
188	NULL
RNA	NULL
bands	NULL
are	NULL
indicated	NULL
.	NULL

1240	NULL
PISE-MASISON	NULL
ET	NULL
AL	NULL
.	NULL

A.	NULL
waar	NULL
r	NULL
--	NULL
)	NULL
3	NULL
}	NULL
r	NULL
fy	NULL
]	NULL
-cour	NULL
in	NULL
9	NULL
BsmFl	NULL
(	NULL
118	NULL
)	NULL
Hind	NULL
II1	NULL
(	NULL
-577	NULL
)	NULL
PpUMI	NULL
(	NULL
-156	NULL
)	NULL
pAB/P	NULL
CAT	NULL
——©—|	NULL
:	NULL
|\\	NULL
|	NULL
.-	NULL
``	NULL
a	NULL
l	NULL
»	NULL
—CCAAT—	NULL
In|___	NULL
CAT	NULL
~	NULL
~	NULL
~	NULL
pAH/P	NULL
CAT	NULL
__	NULL
--	NULL
~~	NULL
—CCAAT—Inr	NULL
Cat	NULL
pBell	NULL
cat	NULL
___	NULL
]	NULL
B.	NULL
Y	NULL
Box	NULL
Sequence	NULL
:	NULL
TCCAGTGCTGATTGGTTTTCCGAGGGA	NULL
Mutant	NULL
Sequence	NULL
:	NULL
TCCAGTGCTGGGCCG	NULL
TCCGAGGGA	NULL
Bol	NULL
I	NULL
Mutant	NULL
Sequence	NULL
:	NULL
TCCAGTGCTGATCAGT	NULL
CCGAGGGA	NULL
C.	NULL
8s	NULL
F	NULL
2	NULL
3	NULL
g-2	NULL
J	NULL
TAX	NULL
-	NULL
21g	NULL
4ug	NULL
Bug	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

MHC	NULL
class	NULL
II	NULL
promoter	NULL
constructs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Diagram	NULL
of	NULL
the	NULL
DQB	NULL
promoter	NULL
constructs	NULL
used	NULL
in	NULL
the	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
restriction	NULL
sites	NULL
and	NULL
nucleotide	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequences	NULL
of	NULL
the	NULL
wild-type	NULL
Y-box	NULL
element	NULL
and	NULL
two	NULL
mutant	NULL
constructs	NULL
used	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Increasing	NULL
amounts	NULL
of	NULL
peTax	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
8	NULL
pg	NULL
)	NULL
or	NULL
the	NULL
vector	NULL
alone	NULL
(	NULL
4	NULL
mg	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
5	NULL
mg	NULL
of	NULL
pDQBCAT	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
collected	NULL
24	NULL
h	NULL
later	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
bars	NULL
represent	NULL
the	NULL
average	NULL
values	NULL
from	NULL
three	NULL
or	NULL
more	NULL
independent	NULL
experiments	NULL
.	NULL

vation	NULL
and	NULL
proliferation	NULL
is	NULL
also	NULL
transcriptionally	NULL
activated	NULL
by	NULL
Tax	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
48	NULL
,	NULL
86	NULL
)	NULL
.	NULL

Abnormal	NULL
expression	NULL
of	NULL
such	NULL
factors	NULL
or	NULL
receptors	NULL
involved	NULL
in	NULL
cell	NULL
growth	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
key	NULL
events	NULL
that	NULL
ultimately	NULL
leads	NULL
to	NULL
the	NULL
development	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
or	NULL
TSP/HAM	NULL
.	NULL

MHC	NULL
class	NULL
II	NULL
genes	NULL
are	NULL
comprised	NULL
of	NULL
a	NULL
large	NULL
family	NULL
of	NULL
highly	NULL
polymorphic	NULL
heterodimeric	NULL
glycoproteins	NULL
.	NULL

The	NULL
functional	NULL
consequence	NULL
of	NULL
this	NULL
variation	NULL
is	NULL
the	NULL
regulation	NULL
and	NULL
restriction	NULL
of	NULL
the	NULL
cellular	NULL
immune	NULL
response	NULL
,	NULL
since	NULL
the	NULL
structure	NULL
of	NULL
each	NULL
class	NULL
II	NULL
molecule	NULL
determines	NULL
which	NULL
peptide	NULL
sequences	NULL
are	NULL
presented	NULL
to	NULL
lymphoid	NULL
cells	NULL
(	NULL
58	NULL
,	NULL
68	NULL
,	NULL
70	NULL
)	NULL
.	NULL

The	NULL
MHC	NULL
class	NULL
II-peptide	NULL
complexes	NULL
determine	NULL
the	NULL
repertoire	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
thus	NULL
play	NULL
a	NULL
fundamental	NULL
role	NULL
in	NULL
the	NULL
homeostasis	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

Quantitative	NULL
and	NULL
qualitative	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
dramatically	NULL
affect	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
and	NULL
may	NULL
be	NULL
the	NULL
basis	NULL
of	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
disease	NULL
states	NULL
(	NULL
51	NULL
)	NULL
.	NULL

By	NULL
cell	NULL
surface	NULL
staining	NULL
,	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
molecule	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
elevated	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
isolated	NULL
from	NULL
HTLV-1-infected	NULL
patients	NULL
as	NULL
compared	NULL
to	NULL
normal	NULL
donors	NULL
(	NULL
3	NULL
,	NULL
47	NULL
,	NULL
64	NULL
,	NULL
92	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
HTLV-1	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

infection	NULL
of	NULL
neuroblastoma	NULL
cells	NULL
or	NULL
transfection	NULL
of	NULL
a	NULL
glial	NULL
cell	NULL
line	NULL
with	NULL
Tax	NULL
demonstrated	NULL
that	NULL
Tax	NULL
activated	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
infection	NULL
by	NULL
bovine	NULL
leukemia	NULL
virus	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
same	NULL
family	NULL
of	NULL
oncogenic	NULL
retroviruses	NULL
as	NULL
HTLV-1	NULL
and	NULL
-2	NULL
,	NULL
causes	NULL
an	NULL
increase	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
by	NULL
infected	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
(	NULL
79	NULL
)	NULL
.	NULL

Iwakura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
reported	NULL
that	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
overex-pression	NULL
of	NULL
MHC	NULL
genes	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
transgenic	NULL
mice	NULL
which	NULL
express	NULL
the	NULL
HTLV-1	NULL
pX	NULL
and	NULL
env	NULL
regions	NULL
develop	NULL
an	NULL
autoimmune	NULL
chronic	NULL
inflammatory	NULL
arthropathy	NULL
resembling	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
evidence	NULL
suggests	NULL
that	NULL
certain	NULL
class	NULL
II	NULL
MHC	NULL
molecules	NULL
are	NULL
associated	NULL
with	NULL
human	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
Hasunuma	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
have	NULL
recently	NULL
reported	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
cytotoxic	NULL
T	NULL
cells	NULL
against	NULL
Tax-bearing	NULL
synoviocytes	NULL
and	NULL
augmentation	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
molecules	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
HTLV-1	NULL
synoviocytes	NULL
.	NULL

Although	NULL
latent	NULL
viral	NULL
replication	NULL
in	NULL
circulating	NULL
infected	NULL
T	NULL
lymphocytes	NULL
is	NULL
a	NULL
common	NULL
feature	NULL
of	NULL
HTLV	NULL
infection	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
circulating	NULL
HTLV-infected	NULL
T	NULL
lymphocytes	NULL
is	NULL
significantly	NULL
increased	NULL
in	NULL
HAM/TSP	NULL
patients	NULL
(	NULL
27	NULL
,	NULL
39	NULL
,	NULL
45	NULL
)	NULL
as	NULL
compared	NULL
to	NULL
in	NULL
asymptomatic	NULL
carriers	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
HTLV-1-specific	NULL
CD4*	NULL
HLA	NULL
class	NULL
II-restricted	NULL
and	NULL
CD8	NULL
*	NULL
class	NULL
I-restricted	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
have	NULL
been	NULL
demonstrated	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
of	NULL
HAM/TSP	NULL
patients	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
is	NULL
hypothesized	NULL
to	NULL
induce	NULL
pathogenesis	NULL
not	NULL
only	NULL
in	NULL
HAM/TSP	NULL
patients	NULL
but	NULL
also	NULL
in	NULL
patients	NULL
with	NULL
arthri-tis	NULL
,	NULL
uveitis	NULL
,	NULL
and	NULL
Sjorgen	NULL
's	NULL
disease	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Tax	NULL
greatly	NULL
contributes	NULL
not	NULL
only	NULL
to	NULL
cellular	NULL
proliferation	NULL
but	NULL
also	NULL
to	NULL
induction	NULL
of	NULL
an	NULL
immune	NULL
response	NULL
through	NULL
deregulation	NULL
of	NULL
MHC	NULL
expression	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
Tax	NULL
interacts	NULL
with	NULL
and	NULL
activates	NULL
transcription	NULL
through	NULL
NF-Y	NULL
provides	NULL
a	NULL
mechanism	NULL
for	NULL
this	NULL
HTLV-1-induced	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

The	NULL
primary	NULL
regulation	NULL
of	NULL
class	NULL
II	NULL
molecule	NULL
expression	NULL
is	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
,	NULL
which	NULL
is	NULL
both	NULL
cell	NULL
type	NULL
and	NULL
development	NULL
stage	NULL
specific	NULL
(	NULL
11	NULL
,	NULL
17	NULL
,	NULL
58	NULL
,	NULL
68	NULL
,	NULL
70	NULL
)	NULL
.	NULL

Our	NULL
work	NULL
demonstrates	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
on	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
mRNA	NULL
.	NULL

The	NULL
MHC	NULL
class	NULL
II	NULL
promoters	NULL
share	NULL
conserved	NULL
sequence	NULL
motifs	NULL
,	NULL
which	NULL
include	NULL
the	NULL
W	NULL
,	NULL
X	NULL
,	NULL
X2	NULL
,	NULL
and	NULL
Y	NULL
boxes	NULL
.	NULL

Nuclear	NULL
factors	NULL
which	NULL
bind	NULL
to	NULL
these	NULL
sequences	NULL
have	NULL
been	NULL
iden-tified	NULL
,	NULL
and	NULL
some	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
17	NULL
,	NULL
68	NULL
,	NULL
70	NULL
,	NULL
84	NULL
)	NULL
.	NULL

Reports	NULL
have	NULL
shown	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
factors	NULL
which	NULL
control	NULL
the	NULL
class	NULL
II	NULL
promoter	NULL
is	NULL
cooperative	NULL
and	NULL
that	NULL
NF-Y	NULL
binding	NULL
facilitates	NULL
in	NULL
vivo	NULL
recruitment	NULL
of	NULL
upstream	NULL
transcription	NULL
factors	NULL
(	NULL
69	NULL
,	NULL
84	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
clearly	NULL
demonstrate	NULL
that	NULL
Tax	NULL
can	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
DQB	NULL
promoter	NULL
through	NULL
the	NULL
NF-Y	NULL
element	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
find	NULL
that	NULL
Tax	NULL
is	NULL
able	NULL
to	NULL
directly	NULL
interact	NULL
with	NULL
the	NULL
NF-YB	NULL
subunit	NULL
.	NULL

Recently	NULL
,	NULL
Matsuzaki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
55	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
Tax	NULL
can	NULL
interact	NULL
with	NULL
a	NULL
CREB-like	NULL
factor	NULL
,	NULL
TREBS5	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
X	NULL
region	NULL
of	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
Tax	NULL
can	NULL
activate	NULL
transcription	NULL
through	NULL
this	NULL
element	NULL
.	NULL

In	NULL
our	NULL
hands	NULL
,	NULL
the	NULL
X	NULL
box	NULL
(	NULL
AH/PCAT	NULL
)	NULL
is	NULL
dispensable	NULL
for	NULL
Tax	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
DQ	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
transactivation	NULL
of	NULL
the	NULL
class	NULL
II	NULL
promoter	NULL
by	NULL
Tax	NULL
is	NULL
elevated	NULL
when	NULL
the	NULL
X	NULL
box	NULL
is	NULL
present	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
cooperative	NULL
effect	NULL
of	NULL
Tax-NF-Y	NULL
and	NULL
an	NULL
upstream	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

NF-Y	NULL
is	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
heteromeric	NULL
CCAAT	NULL
binding	NULL
protein	NULL
composed	NULL
of	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
subunits	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Recently	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
subunits	NULL
of	NULL
NF-Y	NULL
associate	NULL
in	NULL
a	NULL
1:1:1	NULL
ratio	NULL
and	NULL
that	NULL
association	NULL
occurs	NULL
in	NULL
an	NULL
ordered	NULL
fashion	NULL
(	NULL
75	NULL
)	NULL
.	NULL

The	NULL
B	NULL
and	NULL
C	NULL
subunits	NULL
must	NULL
bind	NULL
each	NULL
other	NULL
before	NULL
the	NULL
A	NULL
subunit	NULL
can	NULL
bind	NULL
.	NULL

Interestingly	NULL
,	NULL
NF-YB	NULL
and	NULL
NF-YC	NULL
were	NULL
identified	NULL
as	NULL
having	NULL
H2B	NULL
and	NULL
H2A	NULL
histone-fold	NULL
motifs	NULL
,	NULL
respectively	NULL
(	NULL
8	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
B	NULL
and	NULL
C	NULL
subunits	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
to	NULL
form	NULL
dimers	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
HZA	NULL
Vou	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
INTERACTION	NULL
A	NULL
.	NULL

1	NULL
2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
70	NULL
8	NULL
9	NULL
10	NULL
¥	NULL
t	NULL
0	NULL
0	NULL
0	NULL
o	NULL
ao	NULL
o	NULL
a	NULL
a	NULL
a	NULL
0	NULL
Vector	NULL
pDQCAT	NULL
-	NULL
pAB/PCAT	NULL
-	NULL
pAH/PCAT	NULL
-	NULL
pBeiL	NULL
CAT	NULL
Tax	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
[	NULL
-	NULL
£004	NULL
00-2	NULL
@	NULL
]	NULL
%	NULL
Conver	NULL
7.2	NULL
6.6	NULL
4.5	NULL
21.7	NULL
4.3	NULL
4.0	NULL
7.4	NULL
21.8	NULL
9.4	NULL
12.2	NULL
Fold	NULL
Increase	NULL
1	NULL
5	NULL
1	NULL
3	NULL
1	NULL
B	NULL
Vector	NULL
_	NULL
pDQCAT	NULL
pAB/PCAT	NULL
pAH/PCAT	NULL
pBcil	NULL
CAT	NULL
*	NULL
Tax	NULL
[	NULL
-	NULL
#	NULL
'=	NULL
$	NULL
1	NULL
#	NULL
's	NULL
#	NULL
)	NULL
-	NULL
4	NULL
%	NULL
o	NULL
<	NULL
-	NULL
Tax	NULL
30	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
-	NULL
_	NULL
M47	NULL
+	NULL
M22	NULL
OF	NULL
HTLV-1	NULL
Tax	NULL
AND	NULL
CCAAT	NULL
BINDING	NULL
PROTEIN	NULL
NF-Y	NULL
-	NULL
1241	NULL
C.	NULL
7x	NULL
?	NULL

1009200	NULL
13000	NULL
14	NULL
A~\	NULL
'	NULL
$	NULL
4	NULL
&	NULL
-	NULL
+44	NULL
¢	NULL
5	NULL
@	NULL
#	NULL
4	NULL
i	NULL
%	NULL
gie	NULL
aam	NULL
Nev-	NULL
Wb	NULL
Ans	NULL
ad	NULL
8	NULL
e	NULL
e	NULL
#	NULL
pDQCAT	NULL
-	NULL
M47	NULL
+	NULL
-	NULL
Mz2	NULL
'	NULL
9.7	NULL
29.9	NULL
49.0	NULL
74.1	NULL
3	NULL
5	NULL
8	NULL
pDocat	NULL
§	NULL
)	NULL
<	NULL
-1s*	NULL
Free	NULL
11°	NULL
12	NULL
13	NULL
14	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Tax	NULL
activation	NULL
of	NULL
the	NULL
DQ	NULL
promoter	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
and	NULL
4	NULL
pg	NULL
of	NULL
cither	NULL
pCMV	NULL
vector	NULL
(	NULL
-	NULL
)	NULL
or	NULL
pcTax	NULL
(	NULL
+	NULL
)	NULL
and	NULL
assayed	NULL
24	NULL
h	NULL
later	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
assay	NULL
,	NULL
with	NULL
the	NULL
percent	NULL
conversion	NULL
(	NULL
Conver	NULL
)	NULL
of	NULL
chloramphenicol	NULL
and	NULL
fold	NULL
increase	NULL
by	NULL
Tax	NULL
listed	NULL
below	NULL
the	NULL
lanes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Samples	NULL
from	NULL
each	NULL
transfection	NULL
were	NULL
assayed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
to	NULL
determine	NULL
the	NULL
level	NULL
of	NULL
Tax	NULL
expressed	NULL
.	NULL

Numbers	NULL
on	NULL
the	NULL
left	NULL
are	NULL
molecular	NULL
weights	NULL
in	NULL
thousands	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
6	NULL
pg	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
ng	NULL
of	NULL
*°P-labeled	NULL
Y-box	NULL
sequence	NULL
either	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pg	NULL
of	NULL
wild-type	NULL
(	NULL
W.T	NULL
.	NULL
)	NULL

(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
mutant	NULL
(	NULL
Mut	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
Bell	NULL
mutant	NULL
(	NULL
Bell	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
competitor	NULL
DNA	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
6	NULL
g	NULL
of	NULL
extracts	NULL
was	NULL
preincubated	NULL
with	NULL
either	NULL
1	NULL
pg	NULL
of	NULL
NF-YA	NULL
antibody	NULL
or	NULL
1	NULL
mg	NULL
of	NULL
IgG	NULL
antibody	NULL
of	NULL
the	NULL
same	NULL
isotype	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
NF-Y-bound	NULL
complex	NULL
and	NULL
free	NULL
probe	NULL
are	NULL
indicated	NULL
.	NULL

and	NULL
H2B	NULL
.	NULL

Tax	NULL
could	NULL
facilitate	NULL
complex	NULL
formation	NULL
between	NULL
NF-YB	NULL
and	NULL
NF-YC	NULL
,	NULL
driving	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
A-B-C	NULL
complex	NULL
and	NULL
thus	NULL
elevating	NULL
the	NULL
level	NULL
of	NULL
active	NULL
NF-Y	NULL
DNA	NULL
binding	NULL
factors	NULL
.	NULL

Alternatively	NULL
,	NULL
Tax	NULL
could	NULL
be	NULL
stabilizing	NULL
NF-Y	NULL
complexes	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
NF-YB	NULL
and/or	NULL
could	NULL
increase	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-Y	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
is	NULL
seen	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
35	NULL
,	NULL
42	NULL
)	NULL
.	NULL

To	NULL
date	NULL
there	NULL
has	NULL
been	NULL
no	NULL
evidence	NULL
of	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-Y	NULL
,	NULL
but	NULL
the	NULL
possibility	NULL
exists	NULL
.	NULL

In	NULL
a	NULL
report	NULL
by	NULL
Schmidt	NULL
and	NULL
Schilber	NULL
(	NULL
71	NULL
)	NULL
,	NULL
describing	NULL
a	NULL
difference	NULL
in	NULL
regulation	NULL
between	NULL
NF-YA	NULL
and	NULL
NF-	NULL
YB	NULL
,	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
NF-YB	NULL
are	NULL
regulated	NULL
posttranslationally	NULL
.	NULL

This	NULL
could	NULL
again	NULL
be	NULL
achieved	NULL
by	NULL
nuclear	NULL
localization	NULL
,	NULL
protein	NULL
stabilization	NULL
,	NULL
or	NULL
both	NULL
.	NULL

There	NULL
is	NULL
no	NULL
obvious	NULL
nuclear	NULL
localization	NULL
signal	NULL
in	NULL
NF-YB	NULL
,	NULL
yet	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
protein	NULL
is	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Since	NULL
NF-Y	NULL
is	NULL
a	NULL
heteromeric	NULL
complex	NULL
,	NULL
the	NULL
stoichiometric	NULL
levels	NULL
of	NULL
the	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
subunits	NULL
may	NULL
be	NULL
maintained	NULL
in	NULL
a	NULL
manner	NULL
analogous	NULL
to	NULL
that	NULL
which	NULL
makes	NULL
stability	NULL
of	NULL
IxB	NULL
dependent	NULL
on	NULL
levels	NULL
of	NULL
NF-kB	NULL
(	NULL
12	NULL
,	NULL
73	NULL
,	NULL
80	NULL
)	NULL
.	NULL

NF-Y	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
CCAAT	NULL
motifs	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
eukaryotic	NULL
and	NULL
viral	NULL
genes	NULL
.	NULL

Several	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
involved	NULL
in	NULL
cellular	NULL
regulation	NULL
,	NULL
such	NULL
as	NULL
those	NULL
for	NULL
human	NULL
thymidine	NULL
kinase	NULL
,	NULL
IL-4	NULL
,	NULL
fibroblast	NULL
growth	NULL
factor-4	NULL
,	NULL
and	NULL
ribonucleotide	NULL
reductase	NULL
R2	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
21	NULL
,	NULL
32	NULL
,	NULL
49	NULL
)	NULL
.	NULL

NF-Y	NULL
binding	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
reported	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
regulators	NULL
CDC25C	NULL
and	NULL
CDC2	NULL
(	NULL
15	NULL
,	NULL
93	NULL
)	NULL
both	NULL
of	NULL
which	NULL
are	NULL
important	NULL
for	NULL
progression	NULL
through	NULL
G	NULL
,	NULL
/M	NULL
.	NULL

Recently	NULL
,	NULL
another	NULL
important	NULL
regulator	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
the	NULL
tumor	NULL
suppressor	NULL
protein	NULL
p53	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
NF-Y	NULL
on	NULL
the	NULL
hsp70	NULL
promoter	NULL
,	NULL
causing	NULL
a	NULL
repression	NULL
in	NULL
transcription	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
NF-Y	NULL
in	NULL
HTLV-1-transformed	NULL
cells	NULL
suggests	NULL
that	NULL
Tax	NULL
not	NULL
only	NULL
transcriptionally	NULL
activates	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
but	NULL
may	NULL
also	NULL
activate	NULL
other	NULL
cellular	NULL
genes	NULL
regulated	NULL
by	NULL
NF-Y	NULL
.	NULL

This	NULL
interaction	NULL
may	NULL
also	NULL
have	NULL
an	NULL
important	NULL
impact	NULL
on	NULL
regulation	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
interaction	NULL
that	NULL
we	NULL
observe	NULL
be	NULL
tween	NULL
Tax	NULL
and	NULL
NF-Y	NULL
may	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
cellular	NULL
transformation	NULL
and	NULL
ultimately	NULL
contribute	NULL
to	NULL
HTLV-1	NULL
disease	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Daniel	NULL
Masison	NULL
and	NULL
Nancy	NULL
DiFronzo	NULL
for	NULL
critical	NULL
evaluation	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adya	NULL
,	NULL
N.	NULL
,	NULL
L.-J	NULL
.	NULL

Zhao	NULL
,	NULL
W.	NULL
Huang	NULL
,	NULL
I.	NULL
Boros	NULL
,	NULL
and	NULL
C.-Z	NULL
.	NULL

Giam	NULL
.	NULL

1994	NULL
.	NULL

Expansion	NULL
of	NULL
CREB	NULL
's	NULL
DNA	NULL
recognition	NULL
specificity	NULL
by	NULL
Tax	NULL
results	NULL
from	NULL
interaction	NULL
with	NULL
Ala-Ala-Arg	NULL
at	NULL
positions	NULL
282-284	NULL
near	NULL
the	NULL
conserved	NULL
DNA-binding	NULL
domain	NULL
of	NULL
CREB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5642-5646	NULL
.	NULL

2	NULL
.	NULL

Agoff	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
J.	NULL
Hou	NULL
,	NULL
D.	NULL
I.	NULL
Linzer	NULL
,	NULL
and	NULL
B.	NULL
Wu	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
hsp70	NULL
promoter	NULL
by	NULL
p53	NULL
.	NULL

Science	NULL
259:84-87	NULL
.	NULL

3	NULL
.	NULL

Akari	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Goto	NULL
,	NULL
and	NULL
T.	NULL
Shinjo	NULL
.	NULL

1995	NULL
.	NULL

Detection	NULL
of	NULL
the	NULL
cellular	NULL
membrane	NULL
proteins	NULL
on	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Arch	NULL
.	NULL

Virol	NULL
.	NULL

140:375-382	NULL
.	NULL

4	NULL
.	NULL

Anderson	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
W.	NULL
S.	NULL
Dynan	NULL
.	NULL

1994	NULL
.	NULL

Quantitative	NULL
studies	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
on	NULL
CREB	NULL
protein-DNA	NULL
binding	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:3194-3201	NULL
.	NULL

5	NULL
.	NULL

Armstrong	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Franklin	NULL
,	NULL
M.	NULL
N.	NULL
Uittenbogaard	NULL
,	NULL
H.	NULL
A.	NULL
Geibler	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1993	NULL
.	NULL

Pleiotropic	NULL
effect	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
Tax	NULL
protein	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7303-7307	NULL
.	NULL

6	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
Kingston	NULL
,	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
J.	NULL
Seidman	NULL
,	NULL
J.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
.	NULL

1994	NULL
.	NULL

Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

John	NULL
Wiley	NULL
and	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
7	NULL
.	NULL

Baranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
C.	NULL
R.	NULL
Palmer	NULL
,	NULL
M.	NULL
K.	NULL
Hamm	NULL
,	NULL
H.	NULL
A.	NULL
Giebler	NULL
,	NULL
A.	NULL
Brauweller	NULL
,	NULL
J.	NULL
K.	NULL
Nyborg	NULL
,	NULL
and	NULL
A.	NULL
Schepartz	NULL
.	NULL

1995	NULL
.	NULL

Mechanism	NULL
of	NULL
DNA-binding	NULL
enhancement	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
transactivator	NULL
Tax	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
376:606-608	NULL
.	NULL

8	NULL
.	NULL

Baxevanis	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
G.	NULL
Arents	NULL
,	NULL
E.	NULL
N.	NULL
Moudrianakis	NULL
,	NULL
and	NULL
D.	NULL
Landsman	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
DNA-binding	NULL
and	NULL
multimeric	NULL
proteins	NULL
contain	NULL
the	NULL
histone	NULL
fold	NULL
motif	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:2685-2691	NULL
.	NULL

9	NULL
.	NULL

Boulikas	NULL
,	NULL
T.	NULL
1993	NULL
.	NULL

Nuclear	NULL
localization	NULL
(	NULL
NSL	NULL
)	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Eukaryotic	NULL
Gene	NULL
Expression	NULL
3:193-227	NULL
.	NULL

10	NULL
.	NULL

Brauweiler	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Garl	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Franklin	NULL
,	NULL
H.	NULL
A.	NULL
Giebler	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
molecular	NULL
mechanism	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
latency	NULL
and	NULL
Tax	NULL
transactivation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:12814-12822	NULL
.	NULL

11	NULL
.	NULL

Brodsky	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Guagliardi	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
cell	NULL
biology	NULL
of	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9707-744	NULL
.	NULL

1242	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

PISE-MASISON	NULL
ET	NULL
AL	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-kappa	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
I	NULL
kappa	NULL
B-alpha	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

Bryans	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
M.	NULL
Lucas	NULL
,	NULL
T.	NULL
J.	NULL
Knoboch	NULL
,	NULL
N.	NULL
M.	NULL
Wilkie	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Lang	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
FGF-4	NULL
enhancer	NULL
activity	NULL
by	NULL
transcription	NULL
factor	NULL
NF-Y	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

211:519-527	NULL
.	NULL

Chang	NULL
,	NULL
Z.-F.	NULL
,	NULL
and	NULL
C.-J	NULL
.	NULL

Liu	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
thymidine	NULL
kinase	NULL
CCAAT-binding	NULL
protein	NULL
NF-Y	NULL
,	NULL
whose	NULL
A	NULL
subunit	NULL
expression	NULL
is	NULL
serum-dependent	NULL
in	NULL
human	NULL
IMR-90	NULL
diploid	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:17893-17898	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Campisi	NULL
,	NULL
and	NULL
R.	NULL
Padmanabhan	NULL
.	NULL

1996	NULL
.	NULL

SV40	NULL
large	NULL
T	NULL
antigen	NULL
transactivates	NULL
the	NULL
human	NULL
edc2	NULL
promoter	NULL
by	NULL
inducing	NULL
a	NULL
CCAAT	NULL
box	NULL
binding	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

27:13959-13967	NULL
.	NULL

Clemens	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
G.	NULL
Piras	NULL
,	NULL
M.	NULL
F.	NULL
Radonovich	NULL
,	NULL
K.-S.	NULL
Choi	NULL
,	NULL
J.	NULL
F.	NULL
Duvall	NULL
,	NULL
J.	NULL
DeJong	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1996	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
transactivator	NULL
with	NULL
transcription	NULL
factor	NULL
IIA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4656-4664	NULL
.	NULL

Cogswell	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
N.	NULL
Zeleznik-Le	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:87-112	NULL
.	NULL

Daenke	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Nightingale	NULL
,	NULL
J.	NULL
K.	NULL
Cruickshank	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
M.	NULL
Bangham	NULL
.	NULL

1990	NULL
.	NULL

Sequence	NULL
variants	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
from	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
do	NULL
not	NULL
distinguish	NULL
neurological	NULL
from	NULL
leukemic	NULL
isolates	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1278-1282	NULL
.	NULL

Dittmer	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
D.	NULL
Gitlin	NULL
,	NULL
R.	NULL
L.	NULL
Reid	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1993	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
P2	NULL
promoter	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
by	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
Tax1	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
transcription	NULL
factor	NULL
Ets1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:6087-6095	NULL
.	NULL

Dorn	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Bollekens	NULL
,	NULL
A.	NULL
Straub	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
multiplicity	NULL
of	NULL
CCAAT	NULL
box-binding	NULL
proteins	NULL
.	NULL

Cell	NULL
50:863-872	NULL
.	NULL

Filatov	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
L.	NULL
Thelander	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
a	NULL
proximal	NULL
NF-Y	NULL
binding	NULL
promoter	NULL
element	NULL
in	NULL
S	NULL
phase-specific	NULL
expression	NULL
of	NULL
mouse	NULL
ribonucleotide	NULL
reductase	NULL
R2	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:25239-25243	NULL
.	NULL

Franchini	NULL
,	NULL
G.	NULL
1995	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia/lym-photropic	NULL
virus	NULL
type	NULL
I	NULL
infection	NULL
.	NULL

Blood	NULL
86:3619-3639	NULL
.	NULL

Franklin	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1995	NULL
.	NULL

Mechanism	NULL
of	NULL
Tax	NULL
regulation	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Biomed	NULL
.	NULL

Sci	NULL
.	NULL

2:17-29	NULL
.	NULL

Franklin	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
F.	NULL
Kubik	NULL
,	NULL
M.	NULL
N.	NULL
Uittenbogaard	NULL
,	NULL
A.	NULL
Brauweiler	NULL
,	NULL
P.	NULL
Utais-incharoen	NULL
,	NULL
M.-A	NULL
.	NULL

H.	NULL
Matthews	NULL
,	NULL
W.	NULL
S.	NULL
Dynan	NULL
,	NULL
J.	NULL
P.	NULL
Hoeffler	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1993	NULL
.	NULL

Transactivation	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
Tax	NULL
protein	NULL
is	NULL
mediated	NULL
through	NULL
enhanced	NULL
binding	NULL
of	NULL
activating	NULL
transcription	NULL
factor-2	NULL
(	NULL
ATF-2	NULL
)	NULL
ATF-2	NULL
response	NULL
and	NULL
cAMP	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:21225-21231.	NULL
.	NULL

Fukushima	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
H.	NULL
Ueno	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
HTLV-1	NULL
infected	NULL
cell	NULL
lines	NULL
and	NULL
uveitis	NULL
.	NULL

Graefes	NULL
.	NULL

Arch	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Ophthalmol	NULL
.	NULL

233	NULL
:	NULL
231-235	NULL
.	NULL

Gazzolo	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Duc	NULL
Dodon	NULL
.	NULL

1987	NULL
.	NULL

Direct	NULL
activation	NULL
of	NULL
resting	NULL
T	NULL
lymphocytes	NULL
by	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:714-717	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Saal	NULL
,	NULL
O.	NULL
Gout	NULL
,	NULL
M.	NULL
T.	NULL
Daniel	NULL
,	NULL
G.	NULL
Flandrin	NULL
,	NULL
G.	NULL
de	NULL
The	NULL
,	NULL
J.	NULL
Peries	NULL
,	NULL
and	NULL
F.	NULL
Sigaux	NULL
.	NULL

1990	NULL
.	NULL

High	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
proviral	NULL
DNA	NULL
load	NULL
with	NULL
polyclonal	NULL
integration	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
of	NULL
French	NULL
West	NULL
Indian	NULL
,	NULL
Guianese	NULL
,	NULL
and	NULL
African	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Blood	NULL
75:428-433	NULL
.	NULL

Grassman	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Berchtold	NULL
,	NULL
I.	NULL
Radant	NULL
,	NULL
M.	NULL
Alt	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
W.	NULL
A.	NULL
Haseltine	NULL
,	NULL
and	NULL
U.	NULL
Ramstedt	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
X	NULL
region	NULL
proteins	NULL
in	NULL
immortalization	NULL
of	NULL
primary	NULL
human	NULL
lymphocytes	NULL
in	NULL
culture	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:4570-4575	NULL
.	NULL

Grassman	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Dengler	NULL
,	NULL
I.	NULL
Muller-Fleckenstein	NULL
,	NULL
K.	NULL
McGuire	NULL
,	NULL
M.	NULL
C.	NULL
Dokhler	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Transformation	NULL
to	NULL
continuous	NULL
growth	NULL
of	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
X-region	NULL
genes	NULL
transduced	NULL
by	NULL
a	NULL
Herpesvirus	NULL
saimiri	NULL
vector	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:3351-3355	NULL
.	NULL

Gregersen	NULL
,	NULL
P.	NULL
K.	NULL
1989	NULL
.	NULL

HLA	NULL
class	NULL
II	NULL
polymorphism	NULL
:	NULL
implications	NULL
for	NULL
genetic	NULL
susceptibility	NULL
to	NULL
autoimmune	NULL
disease	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

61:5-19	NULL
.	NULL

Hall	NULL
,	NULL
W.	NULL
,	NULL
C.	NULL
R.	NULL
Liu	NULL
,	NULL
O.	NULL
Schneewind	NULL
,	NULL
H.	NULL
Takahashi	NULL
,	NULL
M.	NULL
H.	NULL
Kaplan	NULL
,	NULL
G.	NULL
Roupe	NULL
,	NULL
and	NULL
A.	NULL
Vahine	NULL
.	NULL

1991	NULL
.	NULL

Deleted	NULL
HTLV-I	NULL
provirus	NULL
in	NULL
blood	NULL
and	NULL
cutancous	NULL
lesions	NULL
of	NULL
patients	NULL
with	NULL
mycosis	NULL
fungoides	NULL
.	NULL

Science	NULL
253:317-320	NULL
.	NULL

Hasan	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Koda	NULL
,	NULL
and	NULL
M.	NULL
Kakinuma	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
upstream	NULL
NF-Y-binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
from	NULL
the	NULL
hst	NULL
promoter	NULL
in	NULL
F9	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:25042-25048	NULL
.	NULL

Hasunuma	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
H.	NULL
Ano	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
synovial	NULL
cell	NULL
clones	NULL
with	NULL
integrated	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

72:90-97	NULL
.	NULL

Hinrichs	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
M.	NULL
Nerenberg	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
transgenic	NULL
mouse	NULL
model	NULL
for	NULL
human	NULL
neurofibromatosis	NULL
.	NULL

Science	NULL
237:1340-1343	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
to	NULL
the	NULL
ankyrin	NULL
motifs	NULL
of	NULL
inhibitory	NULL
factor	NULL
kappa	NULL
B	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kappa	NULL
B	NULL
proteins	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3584-3588	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Petropoulos	NULL
,	NULL
and	NULL
J.	NULL
Lacoste	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
interactions	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

between	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
and	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
complex	NULL
.	NULL

Virology	NULL
214:3-11	NULL
.	NULL

Ito	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Fukuda	NULL
,	NULL
K.	NULL
Murata	NULL
,	NULL
and	NULL
A.	NULL
Kimura	NULL
.	NULL

1983	NULL
.	NULL

Transformation	NULL
of	NULL
intact	NULL
yeast	NULL
cells	NULL
treated	NULL
with	NULL
alkali	NULL
cations	NULL
.	NULL

J.	NULL
Bacteriol	NULL
.	NULL

153:163-168	NULL
.	NULL

Iwakura	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
Saijo	NULL
,	NULL
Y.	NULL
Kioka	NULL
,	NULL
J.	NULL
Nakayama-Yamada	NULL
,	NULL
K.	NULL
Itagaki	NULL
,	NULL
M.	NULL
Tosu	NULL
,	NULL
M.	NULL
Asano	NULL
,	NULL
Y.	NULL
Kanai	NULL
,	NULL
and	NULL
K.	NULL
Kakimoto	NULL
.	NULL

1995	NULL
.	NULL

Autoimmunity	NULL
induction	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
transgenic	NULL
mice	NULL
that	NULL
develop	NULL
chronic	NULL
inflammatory	NULL
arthropathy	NULL
resembling	NULL
rheumatoid	NULL
arthritis	NULL
in	NULL
humans	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:1588-1598	NULL
.	NULL

Jacobson	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Shida	NULL
,	NULL
D.	NULL
E.	NULL
McFarlin	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
S.	NULL
Koenig	NULL
.	NULL

1990	NULL
.	NULL

Circulating	NULL
CD8+	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
specific	NULL
for	NULL
HTLV-I	NULL
in	NULL
patients	NULL
with	NULL
HTLV-L-associated	NULL
neurological	NULL
disease	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:245-248	NULL
.	NULL

Jacobson	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
S.	NULL
Reuben	NULL
,	NULL
R.	NULL
D.	NULL
Streilein	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Palker	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
CD4+	NULL
,	NULL
human	NULL
T	NULL
lymphotropic	NULL
type-I-specific	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
HAM/TSP	NULL
.	NULL

Recognition	NULL
of	NULL
an	NULL
immunogenic	NULL
region	NULL
of	NULL
the	NULL
gp46	NULL
envelope	NULL
glycoprotein	NULL
of	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type-I	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1155-1162	NULL
.	NULL

Kannagi	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Matsushita	NULL
,	NULL
H.	NULL
Shida	NULL
,	NULL
and	NULL
S.	NULL
Harada	NULL
.	NULL

1994	NULL
.	NULL

Cytotoxic	NULL
T	NULL
cell	NULL
response	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
target	NULL
antigen	NULL
in	NULL
HTLV-infection	NULL
.	NULL

Leukemia	NULL
8	NULL
(	NULL
Suppl	NULL
.	NULL

1	NULL
)	NULL
:	NULL
§54-	NULL
$	NULL
59	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

Evidence	NULL
in	NULL
support	NULL
of	NULL
a	NULL
role	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
in	NULL
activating	NULL
NF-kappa	NULL
B	NULL
via	NULL
stimulation	NULL
of	NULL
signaling	NULL
pathways	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6443-6451	NULL
.	NULL

Kimata	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1991	NULL
.	NULL

Temporal	NULL
regulation	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
gene	NULL
expression	NULL
during	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I-mediated	NULL
lymphocyte	NULL
immortalization	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4398-4407	NULL
.	NULL

Kinoshita	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Tsujimoto	NULL
,	NULL
K.	NULL
Shimotohno	NULL
,	NULL
and	NULL
T.	NULL
Sugimura	NULL
.	NULL

1991	NULL
.	NULL

Sc-quence	NULL
variations	NULL
in	NULL
LTR	NULL
and	NULL
env	NULL
regions	NULL
of	NULL
HTLV-I	NULL
do	NULL
not	NULL
discriminate	NULL
between	NULL
the	NULL
virus	NULL
from	NULL
patients	NULL
with	NULL
HTLV-I-associated	NULL
myelopathy	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
47:491-495	NULL
.	NULL

Kira	NULL
,	NULL
J.	NULL
,	NULL
Y.	NULL
Itoyama	NULL
,	NULL
Y.	NULL
Koyanagi	NULL
,	NULL
J.	NULL
Tateishi	NULL
,	NULL
M.	NULL
Kishikawa	NULL
,	NULL
S.	NULL
Akizuki	NULL
,	NULL
I.	NULL
Kobayashi	NULL
,	NULL
N.	NULL
Toki	NULL
,	NULL
K.	NULL
Sueishi	NULL
,	NULL
H.	NULL
Sato	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
.	NULL

Presence	NULL
of	NULL
HTLV-I	NULL
proviral	NULL
DNA	NULL
in	NULL
central	NULL
nervous	NULL
system	NULL
of	NULL
patients	NULL
with	NULL
HTLV-I-associated	NULL
myelopathy	NULL
.	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

31:39-45	NULL
.	NULL

LaGrenada	NULL
,	NULL
L.	NULL
,	NULL
B.	NULL
Hanchard	NULL
,	NULL
V.	NULL
Fletcher	NULL
,	NULL
B.	NULL
Cranston	NULL
,	NULL
and	NULL
W.	NULL
Blattner	NULL
.	NULL

1990	NULL
.	NULL

Infective	NULL
dermatitis	NULL
of	NULL
Jamaican	NULL
children	NULL
:	NULL
a	NULL
marker	NULL
for	NULL
HTLV-I	NULL
infection	NULL
.	NULL

Lancet	NULL
336:1345-1347	NULL
.	NULL

Lehky	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
E.	NULL
P.	NULL
Cowan	NULL
,	NULL
L.	NULL
A.	NULL
Lampson	NULL
,	NULL
and	NULL
S.	NULL
Jacobson	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
HLA	NULL
class	NULL
I	NULL
and	NULL
II	NULL
expression	NULL
in	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I-in-fected	NULL
neuroblastoma	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:1854-1863	NULL
.	NULL

Lindholm	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
F.	NULL
Kashanchi	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1993	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
the	NULL
human	NULL
retrovirus	NULL
HTLV-I	NULL
.	NULL

Semin	NULL
.	NULL

Virol	NULL
.	NULL

453-60	NULL
.	NULL

Li-Weber	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
V.	NULL
Davydov	NULL
,	NULL
H.	NULL
Krafft	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Krammer	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NF-Y	NULL
and	NULL
IRF-2	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
IL-4	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:4122-4133	NULL
.	NULL

Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Schutz	NULL
.	NULL

1987	NULL
.	NULL

CAT	NULL
constructions	NULL
with	NULL
multiple	NULL
unique	NULL
restriction	NULL
sites	NULL
for	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:5490	NULL
.	NULL

Mach	NULL
,	NULL
B	NULL
.	NULL

1995	NULL
.	NULL

MHC	NULL
class	NULL
II	NULL
regulation-lessons	NULL
from	NULL
a	NULL
disease	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

332:120-122	NULL
.	NULL

Maity	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
S.	NULL
Sinha	NULL
,	NULL
E.	NULL
C.	NULL
Ruteshousher	NULL
,	NULL
and	NULL
B.	NULL
de	NULL
Crombrugghe	NULL
.	NULL

1992	NULL
.	NULL

Three	NULL
different	NULL
polypeptides	NULL
are	NULL
necessary	NULL
for	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
mammalian	NULL
heteromeric	NULL
CCAAT	NULL
binding	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:16574-16580	NULL
.	NULL

Mann	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
P.	NULL
DeSantis	NULL
,	NULL
G.	NULL
Mark	NULL
,	NULL
A.	NULL
Pfeifer	NULL
,	NULL
M.	NULL
Newman	NULL
,	NULL
N.	NULL
Gibbs	NULL
,	NULL
M.	NULL
Popovic	NULL
,	NULL
M.	NULL
G.	NULL
Sarngadharan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
J.	NULL
Clark	NULL
,	NULL
and	NULL
W.	NULL
Blattner	NULL
.	NULL

1987	NULL
.	NULL

HTLV-I	NULL
associated	NULL
B-cell	NULL
CLL	NULL
:	NULL
indirect	NULL
role	NULL
for	NULL
retrovirus	NULL
in	NULL
leukemogenesis	NULL
.	NULL

Science	NULL
236:1103-1106	NULL
.	NULL

Marcil	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Higgins	NULL
.	NULL

1992	NULL
.	NULL

Direct	NULL
transfer	NULL
of	NULL
plasmid	NULL
DNA	NULL
from	NULL
yeast	NULL
to	NULL
E.	NULL
coli	NULL
by	NULL
electroporation	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:917	NULL
.	NULL

Matsuzaki	NULL
,	NULL
Y.	NULL
,	NULL
J.-L	NULL
Fujisawa	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
TREB5	NULL
,	NULL
a	NULL
CREB/ATF	NULL
family	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
HTLV-1	NULL
enhancer	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

117:303-308	NULL
.	NULL

Matthews	NULL
,	NULL
M.-A	NULL
.	NULL

H.	NULL
,	NULL
R.-B	NULL
.	NULL

Markowitz	NULL
,	NULL
and	NULL
W.	NULL
S.	NULL
Dynan	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1986-1996	NULL
.	NULL

McKinsey	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
S.	NULL
W.	NULL
Al-Murrani	NULL
,	NULL
P.	NULL
L.	NULL
Green	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1996	NULL
.	NULL

Inactivation	NULL
of	NULL
IBB	NULL
by	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
constitutive	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2083-2090	NULL
.	NULL

Monaco	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
genes	NULL
in	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
region	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

5:17-20	NULL
.	NULL

Mori	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Nobutaro	NULL
,	NULL
and	NULL
K.	NULL
Kinoshita	NULL
.	NULL

1988	NULL
.	NULL

Familial	NULL
occurrence	NULL
of	NULL
HTLV-associated	NULL
myelopathy	NULL
.	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

23:100	NULL
.	NULL

Mukhopadhyaya	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Sadaie	NULL
.	NULL

1993	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
analysis	NULL
of	NULL
HTLV-I	NULL
isolated	NULL
from	NULL
cerebrospinal	NULL
fluid	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
TSP/HAM	NULL
.	NULL

Comparison	NULL
to	NULL
other	NULL
HTLV-I	NULL
isolates	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
9:109-114	NULL
.	NULL

Munoz	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
by	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
HTLV-I	NULL
.	NULL

Immunobiol	NULL
.	NULL

193:128-136	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
induces	NULL
mesenchymal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
237:1324-1329	NULL
.	NULL

Nishioka	NULL
,	NULL
K.	NULL
,	NULL
L	NULL
Maruyama	NULL
,	NULL
K.	NULL
Sato	NULL
,	NULL
L	NULL
Kitajima	NULL
,	NULL
Y.	NULL
Nakajima	NULL
,	NULL
and	NULL
M.	NULL
Osame	NULL
.	NULL

1989	NULL
.	NULL

Chronic	NULL
inflammatory	NULL
arthropathy	NULL
associated	NULL
with	NULL
HTLV-I	NULL
.	NULL

Lancet	NULL
iid41	NULL
.	NULL

Noraz	NULL
,	NULL
N.	NULL
,	NULL
B.	NULL
Verrier	NULL
,	NULL
C.	NULL
Fraisier	NULL
,	NULL
and	NULL
C.	NULL
Desgranges	NULL
.	NULL

1995	NULL
.	NULL

Cell	NULL
surface	NULL
phenotype	NULL
changes	NULL
induced	NULL
in	NULL
H9	NULL
T	NULL
cells	NULL
chronically	NULL
infected	NULL
with	NULL
HTLV	NULL
type	NULL
I	NULL
or	NULL
HIV	NULL
type	NULL
I	NULL
or	NULL
coinfected	NULL
with	NULL
the	NULL
two	NULL
viruses	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
11:145-154	NULL
.	NULL

Ohshima	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Kikuchi	NULL
,	NULL
Y.	NULL
Masuda	NULL
,	NULL
Y.	NULL
Sumiyoshi	NULL
,	NULL
F.	NULL
Eguchi	NULL
,	NULL
H.	NULL
Mohtai	NULL
,	NULL
M.	NULL
Takeshita	NULL
,	NULL
and	NULL
N.	NULL
Kimura	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
associated	NULL
lymphadenitis	NULL
.	NULL

Cancer	NULL
69:239-248	NULL
.	NULL

Paca-Uccaralertkun	NULL
,	NULL
S.	NULL
,	NULL
L.-J	NULL
.	NULL

Zhao	NULL
,	NULL
N.	NULL
Adya	NULL
,	NULL
J.	NULL
V.	NULL
Cross	NULL
,	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
I.	NULL
Boros	NULL
,	NULL
and	NULL
C.-Z	NULL
.	NULL

Giam	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
vitro	NULL
selection	NULL
of	NULL
DNA	NULL
elements	NULL
highly	NULL
responsive	NULL
to	NULL
the	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:456-462	NULL
.	NULL

Pozzatti	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Vogel	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Jay	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
gene	NULL
can	NULL
cooperate	NULL
with	NULL
ras	NULL
oncogene	NULL
to	NULL
induce	NULL
neoplastic	NULL
transformation	NULL
in	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:413-417	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
M.	NULL
Kobr	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
.	NULL

Immunobiology	NULL
193:248-253	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
C.-A	NULL
.	NULL

Siegrist	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
E.	NULL
Barras	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
promoters	NULL
requires	NULL
cooperative	NULL
binding	NULL
between	NULL
factors	NULL
RFX	NULL
and	NULL
NF-Y	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
:	NULL
554-558	NULL
.	NULL

Sartoris	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Accolla	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Res	NULL
.	NULL

25:71-78	NULL
.	NULL

Schmidt	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1995	NULL
.	NULL

Cell	NULL
size	NULL
regulation	NULL
,	NULL
a	NULL
mechanism	NULL
that	NULL
controls	NULL
cellular	NULL
RNA	NULL
accumulation	NULL
:	NULL
consequences	NULL
on	NULL
regulation	NULL
of	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
Oct1	NULL
and	NULL
NF-Y	NULL
and	NULL
the	NULL
liver-enriched	NULL
transcription	NULL
factor	NULL
DBP	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

128:467-483	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
,	NULL
1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Scott	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kappa	NULL
B	NULL
regulates	NULL
I	NULL
kappa	NULL
B	NULL
by	NULL
two	NULL
distinct	NULL
mechanisms	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1266-1276	NULL
.	NULL

Shirabe	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Nakamura	NULL
,	NULL
M.	NULL
Tsujihata	NULL
,	NULL
S.	NULL
Nagataki	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1990	NULL
.	NULL

Retrovirus	NULL
from	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
associated	NULL
myelopathy	NULL
is	NULL
the	NULL
same	NULL
strain	NULL
as	NULL
a	NULL
prototype	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Arch	NULL
.	NULL

Neurol	NULL
.	NULL

47:1258-1260	NULL
.	NULL

Sinha	NULL
,	NULL
S.	NULL
,	NULL
I.-S.	NULL
Kim	NULL
,	NULL
K.-Y	NULL
.	NULL

Sohn	NULL
,	NULL
B.	NULL
de	NULL
Crombrugghe	NULL
,	NULL
and	NULL
S.	NULL
N.	NULL
Maity	NULL
.	NULL

1996	NULL
.	NULL

Three	NULL
classes	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
A	NULL
subunit	NULL
of	NULL
the	NULL
CCAAT-binding	NULL
factor	NULL
CBF	NULL
delineate	NULL
functional	NULL
domains	NULL
involved	NULL
in	NULL
the	NULL
three-step	NULL
assembly	NULL
of	NULL
the	NULL
CBF-DNA	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:328-337	NULL
.	NULL

Sinha	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
N.	NULL
Maity	NULL
,	NULL
J.	NULL
Lu	NULL
,	NULL
and	NULL
B.	NULL
de	NULL
Crombrugghe	NULL
.	NULL

1995	NULL
.	NULL

Recombinant	NULL
rat	NULL
CBF-C	NULL
,	NULL
the	NULL
third	NULL
subunit	NULL
of	NULL
CBF/NFY	NULL
,	NULL
allows	NULL
formation	NULL
of	NULL
a	NULL
protein-DNA	NULL
complex	NULL
with	NULL
CBF-A	NULL
and	NULL
CBF-B	NULL
and	NULL
with	NULL
yeast	NULL
HAP2	NULL
and	NULL
HAP3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:1624-1628	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
Tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
through	NULL
the	NULL
cyclic	NULL
adenosine	NULL
mono-phosphate	NULL
response	NULL
element	NULL
binding	NULL
protein/activating	NULL
transcription	NULL
factor	NULL
pathway	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88:1038-1042	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-I	NULL
tax	NULL
trans-	NULL
INTERACTION	NULL
OF	NULL
HTLV-1	NULL
Tax	NULL
AND	NULL
CCAAT	NULL
BINDING	NULL
PROTEIN	NULL
NF-Y	NULL
79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

90	NULL
.	NULL

91	NULL
.	NULL

92	NULL
.	NULL

93	NULL
.	NULL

1243	NULL
activator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

41875-1885	NULL
.	NULL

Stone	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
A.	NULL
J.	NULL
Hof	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Up-regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
alpha	NULL
and	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
on	NULL
lymphocyte	NULL
subpopulations	NULL
from	NULL
bovine	NULL
leukemia	NULL
virus	NULL
infected	NULL
lymphocytotic	NULL
cows	NULL
.	NULL

Vet	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

48:65-76	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-kappa	NULL
B	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
I	NULL
kappa	NULL
B	NULL
alpha	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
JL	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
transactivator	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
interacts	NULL
with	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
and	NULL
CRE	NULL
modulator	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21-base-pair	NULL
enhancer	NULL
of	NULL
HTLV-I	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:610-614	NULL
.	NULL

Tanka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
Tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1993	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
protein	NULL
stimulation	NULL
of	NULL
DNA	NULL
binding	NULL
of	NULL
bZIP	NULL
proteins	NULL
by	NULL
enhancing	NULL
dimerization	NULL
.	NULL

Science	NULL
262:395-399	NULL
.	NULL

Wright	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
B.	NULL
J.	NULL
Vilen	NULL
,	NULL
Y.	NULL
Itoh-Lindstrom	NULL
,	NULL
T.	NULL
L.	NULL
Moore	NULL
,	NULL
G.	NULL
Li	NULL
,	NULL
M.	NULL
Crisci-tiello	NULL
,	NULL
P.	NULL
Cogswell	NULL
,	NULL
J.	NULL
Badley	NULL
Clarke	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1994	NULL
.	NULL

CCAAT	NULL
box	NULL
binding	NULL
protein	NULL
NF-Y	NULL
facilitates	NULL
in	NULL
vivo	NULL
recruitment	NULL
of	NULL
upstream	NULL
DNA	NULL
binding	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4042-4053	NULL
.	NULL

Yamaoka	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Inoue	NULL
,	NULL
M.	NULL
Sakurai	NULL
,	NULL
T.	NULL
Sugiyama	NULL
,	NULL
M.	NULL
Hazama	NULL
,	NULL
T.	NULL
Yamada	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1996	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
essential	NULL
for	NULL
transformation	NULL
of	NULL
rat	NULL
fibroblasts	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:873-887	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
1993	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
:	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
and	NULL
disease	NULL
.	NULL

Trends	NULL
Microbiol	NULL
.	NULL

1:131-135	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Osame	NULL
,	NULL
K.	NULL
Usuki	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
and	NULL
A.	NULL
Igata	NULL
.	NULL

1987	NULL
.	NULL

Virus	NULL
detected	NULL
in	NULL
HTLV-I-associated	NULL
myelopathy	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
are	NULL
identical	NULL
on	NULL
DNA	NULL
blotting	NULL
.	NULL

Lancet	NULL
i:1085-1086	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Osame	NULL
,	NULL
H.	NULL
Kawai	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
N.	NULL
Kuwasaki	NULL
,	NULL
Y.	NULL
Nishida	NULL
,	NULL
Y.	NULL
Hiraki	NULL
,	NULL
K.	NULL
Takahashi	NULL
,	NULL
K.	NULL
Nomura	NULL
,	NULL
S.	NULL
Sonoda	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
.	NULL

Increased	NULL
replication	NULL
of	NULL
HTLV-I	NULL
in	NULL
HTLV-associated	NULL
myelopathy	NULL
.	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

26:331-335	NULL
.	NULL

Zeleznik-Le	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
J.	NULL
C.	NULL
Azizkhan	NULL
,	NULL
and	NULL
J.	NULL
P.-Y	NULL
.	NULL

Ting	NULL
.	NULL

1991	NULL
.	NULL

Affinity-purified	NULL
CCAAT-box-binding	NULL
protein	NULL
(	NULL
YEBP	NULL
)	NULL
functionally	NULL
regulates	NULL
expression	NULL
of	NULL
a	NULL
human	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
gene	NULL
and	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:1873-1837	NULL
.	NULL

Zervos	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
J.	NULL
Gyuris	NULL
,	NULL
and	NULL
R.	NULL
Brent	NULL
.	NULL

1993	NULL
.	NULL

Mix1	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
specifically	NULL
interacts	NULL
with	NULL
Max	NULL
to	NULL
bind	NULL
Myc-Max	NULL
recognition	NULL
sites	NULL
.	NULL

Cell	NULL
72:223-232	NULL
.	NULL

Zhao	NULL
,	NULL
L.-J	NULL
.	NULL

,	NULL
and	NULL
C.-Z	NULL
.	NULL

Giam	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
enhances	NULL
CREB	NULL
binding	NULL
to	NULL
HTLV-I	NULL
21-base-pair	NULL
repeats	NULL
by	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7070-7074	NULL
.	NULL

Zhao	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
M.	NULL
A.	NULL
Robinson	NULL
,	NULL
F.	NULL
S.	NULL
Bowers	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Kindt	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
infectious	NULL
molecular	NULL
clone	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
J.	NULL
Virol	NULL
.	NULL

69:2024-2030	NULL
.	NULL

Zwicker	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Gross	NULL
,	NULL
F.	NULL
C.	NULL
Lucibello	NULL
,	NULL
M.	NULL
Truss	NULL
,	NULL
F.	NULL
Ehlert	NULL
,	NULL
K.	NULL
Engeland	NULL
,	NULL
and	NULL
R.	NULL
Muller	NULL
.	NULL

1995	NULL
.	NULL

Cell	NULL
cycle	NULL
regulation	NULL
of	NULL
edc25C	NULL
transcription	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
periodic	NULL
repression	NULL
of	NULL
the	NULL
glutamine-rich	NULL
activators	NULL
NF-Y	NULL
and	NULL
Spl	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:3822-3830	NULL
.	NULL

